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Abstract
Acetylcholine Signaling in the Basolateral Amygdala During Reward Learning
Richard Blake Crouse
2021
Animal survival relies in part on the ability to learn the outcomes that
environmental stimuli predict and recall those associations to make decisions later in life.
Learning is not monolithic, but instead is mediated by different brain regions depending
on the type of information processed. Learning can happen at happen at different speeds,
and memories can vary in their longevity. Much is still unknown about the neurobiology
underlying learning and memory, thus further research into these processes is necessary
to build foundational understanding of these critical phenomenon, and also to develop
novel treatments for patients suffering from learning and memory related disorders such
as Alzheimer’s Disease, addiction, and post-traumatic stress disorder.
Memories that have a positive or negative emotional association are powerful and
long-lasting. The basolateral amygdala (BLA) is a brain area involved in emotional
processing, including associating initially neutral cues with the appetitive or aversive
stimuli they come to predict. Acetylcholine (ACh), a neuromodulator with abundant
release in the BLA, is implicated in many processes throughout the brain and body, not
least of which is learning and memory. The following chapters detail my exploration of
the connection between BLA ACh signaling and cue-reward learning. After explaining
the background behind and rationale for the approach (Chapter 1), I briefly describe the
development of a cue-reward learning task used to study the role of cholinergic signaling
in appetitive learning (Chapter 2). Then, I discuss experiments we performed to record
(Chapter 3) and manipulate (Chapter 4) BLA cholinergic signaling during this cuereward learning. I conclude by integrating the results from recording and manipulation
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studies and attempt to reconcile these results internally and with external findings to
move toward a more comprehensive understanding of the effect of BLA ACh signaling
during reward learning (Chapter 5).
The primary behavioral paradigm used in the following chapters was a cuereward learning task in which mice must learn to nose poke during presentation of an
auditory tone to receive a food reward. In Chapter 3, we used a genetically-encoded
fluorescent ACh sensor to record ACh dynamics in the BLA as animals learned the task
contingency. We found that ACh was released in the BLA in response to salient events
during the task and evolved with task performance. In order to isolate the source of the
ACh, we also recorded calcium dynamics in the BLA-projecting cholinergic terminal
fibers of nucleus basalis of Meynert (NBM), a basal forebrain nucleus that is a main
contributor of ACh to the BLA. The pattern of activity in these terminal fibers was
similar to that observed for ACh signaling, suggesting that the NBM is responsible, at
least in part, for cue-reward ACh signaling. Importantly, these shifts in time-locking were
tightly correlated to acquisition of the task contingency. We also recorded the activity of
BLA output cells, which revealed they were excited following reward-retrieval initially,
but their response shifted to the reward-predictive tone after acquisition.
Next, in Chapter 4, we optogenetically and pharmacologically modulated
cholinergic signaling in the BLA and systemically investigated the effect of manipulating
cholinergic signaling on reward learning. We found that both behaviorally-contingent and
non-contingent stimulation of BLA ACh release enhanced cue-reward learning. Systemic
antagonism of muscarinic, but not nicotinic, ACh receptors impaired task acquisition.
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Interestingly, nicotine administration led to a modest improvement in performance of the
cue-reward task.
The studies described here advance the understanding of how ACh might be
involved in cue-reward learning and challenge notions of the precise timing required for
neuromodulatory input to affect the formation of associations between stimuli.
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1. Chapter 1: Introduction
The capacity to learn from experiences and store that information as a memory to
recall later is critical for enabling animals to find food, avoid predators, and other
behaviors needed for survival. However, the characteristics of the associations we form
between environmental stimuli and the outcomes they predict can vary wildly. For
instance, why is it that some of these associations are cemented with just a single
experience and stay with us for the rest of our lives while others take multiple repetitions
to stick temporarily? Memory has been the subject of wonder and inquiry for millennia
and modern neuroscience has catapulted us on the trajectory of unlocking more of its
mysteries for the sake of knowledge and human health. Better understanding which brain
chemicals, processes, and areas are involved governing the speed of learning and strength
of memories could have profound implications for treating those suffering from learning
and memory disorders such as addiction, PTSD, and Alzheimer’s.

The role of acetylcholine in learning and memory
To begin a discussion of the changes in the brain that underlie learning and
memory, it might be useful to start with the first neurotransmitter discovered. In the
nearly 100 years since its discovery, much progress has been made in understanding
acetylcholine’s (ACh) myriad effects in the brain and body (Tansey, 2006). Peripheral
effects include eliciting muscle contraction (Merlie et al., 1978) and slowing heart rate
(Hunt & De M. Taveau, 1906) while in the central nervous system, ACh can modulate
communication between neurons, network synchrony, and synaptic plasticity (Picciotto et
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al., 2012). Perhaps not surprising due to its profound influence on neuronal activity
throughout the brain, ACh signaling has been shown to play a role in many critical
cognitive processes such as arousal, sensory perception, attention, reward, learning, and
memory (Ballinger et al., 2016; Knox, 2016; Luchicchi et al., 2014; Picciotto et al.,
2012). Tragically, some of the research underlying the connection between ACh and
learning and memory come from patients with Alzheimer’s Disease (AD) (Ballinger et
al., 2016; Geula & Mesulam, 1989; Nakano & Hirano, 1984; Whitehouse et al., 1981).
AD patients have fewer neurons in the BF (Grothe et al., 2012; Whitehouse et al., 1981),
decreased cortical ACh markers (Geula & Mesulam, 1989), and muscarinic antagonists
mimic AD memory impairments (Drachman, 1974; Newhouse, 1988).
Many recent studies have investigated the role of ACh signaling in processes
related to learning and memory. ACh transients can be measured in prefrontal cortex
(PFC), following detection of a reward-predictive stimulus (Parikh et al., 2007) and
optogenetic modulation of ACh signaling can bidirectionally alter detection of cues
(Gritton et al., 2016). In mice trained to report cued and non-cued trials, heightened ACh
release in PFC enhanced correct responses as well as false alarms while inhibition of
ACh release reduced correct responses rates (Gritton et al., 2016), suggesting a delicate
balance of ACh signaling may be critical for generating behavioral responses to cues.
ACh signaling in visual cortex likewise improves performance in a visual discrimination
task (Pinto et al., 2013) and is necessary for the acquisition, but not expression, of reward
timing in neuronal activity patterns (Chubykin et al., 2013), indicating a role for ACh
signaling in discriminating between stimuli transiently as well as learning-related effects
that outlast an ACh release event. Cholinergic neurons have been shown to respond to
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both positive and negative reinforcers and their responses are scaled by unexpectedness
(Hangya et al., 2015). Cholinergic neuronal responses themselves exhibit plasticity across
learning (Guo et al., 2019; Sturgill et al., 2020) and support plasticity in a number of
regions such as auditory (Guo et al., 2019), motor (Conner et al., 2003), and visual
cortices (Chubykin et al., 2013; Liu et al., 2015), further illustrating the prime position
ACh signaling occupies to coordinate and shape brain activity during learning.
Before diving further into how ACh impacts learning and memory, it is
worthwhile to appreciate where this neuromodulator comes from and how it interacts
with networks of neurons. Cholinergic cells can be divided into two main classes: local
interneurons and projection neurons. Cholinergic interneurons are primarily located in the
striatum while the vast, complex cholinergic projections found throughout cortical and
subcortical structures originate largely from the basal forebrain (BF) complex and the
brainstem (Ballinger et al., 2016; Picciotto et al., 2012). The release profile of ACh from
these projection neurons, is still a subject of controversy (Disney & Higley, 2020; Sarter
& Lustig, 2020). This debate centers on whether ACh release can be characterized as fast,
synaptic, phasic pulses that are spatially confined and rapidly affect the postsynaptic cell
or if it is slower in nature due to a non-synaptic, volume transmission release profile
where diffusion carries ACh beyond an individual synapse to affect a number of recipient
cells (Disney & Higley, 2020; Picciotto et al., 2012; Sarter & Lustig, 2020). The latter
view partly hinged on recording techniques that operated on the order of minutes and a
discrepancy between the location of ACh release sites and postsynaptic ACh receptors,
with studies investigating the prevalence of synapses at cholinergic varicosities reporting
percentages that range from 7-76% (Disney & Higley, 2020; Picciotto et al., 2012; Sarter
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& Lustig, 2020). More recent work has demonstrated that central ACh signaling can
indeed be released in short-latency, phasic manner. Instead of weighing the merits of
each side of the debate, I believe we would be best served to recognize that both release
profiles are probably utilized by the brain (Disney & Higley, 2020).
ACh is considered a neuromodulator because it does not fit neatly into the
category of excitatory or inhibitory neurotransmitter, but instead works to modify the
response profiles of neurons, leading to a change in state of the circuit (Picciotto et al.,
2012). For instance, cholinergic signaling can shift the excitability of a brain area by both
potentiating release of glutamatergic afferent input and increasing the firing rate of a
group of neurons (Jiang et al., 2016; Picciotto et al., 2012). ACh affects neurons through
two families of receptors: nicotinic and muscarinic. Nicotinic ACh receptors (nAChRs)
are pentameric, non-selective cation channels that underlie the short latency, excitatory
responses to ACh. These ionotropic receptors can be heteromeric or homomeric and are
composed of α- and β-subunits (Picciotto et al., 2012). Muscarinic ACh receptors
(mAChRs) are slower acting, metabotropic, and can be further divided into M1 type (M1,
M3, M5) that are Gq/s coupled (activating phospholipase C and increasing cyclic AMP
levels) and M2 type (M2 and M4) that are Gi/o coupled (inhibiting adenylyl cyclase)
(Ballinger et al., 2016; D. A. Brown, 2010; Picciotto et al., 2012; Thiele, 2013; Traish et
al., 1997). The metabotropic coupling of mAChRs to G-proteins allows them to influence
cell activity via modulation of potassium, calcium, and other ion channels, in addition to
biochemical signaling cascades set in motion by second messengers. Recent work has
shown that some nAChRs also function metabotropically, enabling them to affect cell
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activity on the wider temporal and spatial scales thought to be enjoyed only by mAChRs
(Ballinger et al., 2016; Kabbani & Nichols, 2018).
Not only does ACh originate from different regions in the brain and signal
through different types of receptors, but ACh receptors (AChRs) are also distributed
differentially across cell types. AChRs exist pre- and postsynaptically on both principal
cells and interneurons (Ballinger et al., 2016; Picciotto et al., 2012). The configuration of
subtypes and cellular localization of mAChRs and nAChRs on principal neurons and
interneurons, as well as neurotransmitter released as a result, can vary by brain region.
For instance, in the ventral tegmental area, activation of α7 and α4β2 nAChRs result in
the release of glutamate and GABA, respectively (Mansvelder et al., 2002), while
thalamic inputs to prefrontal cortex release glutamate following stimulation of β2containing nAChRs (Parikh et al., 2010; Picciotto et al., 2012). Thus, it is an
oversimplification to categorize ACh’s impact on a network being solely inhibitory or
excitatory. Further complicating matters, the activity level of a recipient cell at the time
of ACh signaling may also impact the ultimate result (Unal et al., 2015). In an attempt to
avoid exhaustively listing the characteristics of ACh signaling, it would be relevant to
end noting that both classes of receptors are involved in plasticity across the brain, a
fundamental process underlying learning and memory.

Emotionally charged learning and memory
There are many different types of learning and memory, such as those used to
acquire and store the skill of riding a bike, a relative’s name, the path from home to work,
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and the emotion(s) tied to a particular scent. These differ in the brain regions they
primarily employ, such as the navigation example relying on the hippocampus and
associated structures while the ability to ride a bike involves the motor cortex, striatum,
and cerebellum (Squire, 2004; Thompson & Kim, 1996). Yet, even a specific type of
memory is typically not secluded to one brain area and requires communication between
multiple structures.
I am particularly interested in the acquisition of emotionally salient memories
because they are the remnants of some of the most impactful experiences and can
drastically shape our behavior moving forward. These range from the highs of finding a
mate or enjoying a favorite food to negative experiences such as a traumatic event. If the
experience is salient enough, it has the potential to influence behavior for the rest of our
lives, for better or worse. While aversive and appetitive memories may initially seem
unrelated or even opposites, there is a large body of evidence to suggest that both are
encoded in part by the basolateral amygdala complex (BLA) (Janak & Tye, 2015).
The BLA is a collection of subcortical nuclei, made up of primarily glutamatergic
principal cells and roughly 15% GABAergic interneurons that receive input from the
sensory and frontal cortices, thalamus, and hippocampus, among other regions (Janak &
Tye, 2015; Pignatelli & Beyeler, 2019; Stamatakis et al., 2014). Many of those input
structures in turn receive projections from the BLA, plus areas such as the nucleus
accumbens, bed nucleus of the stria terminalis, other amygdala nuclei, and more,
suggesting that there BLA may be integrating information and performing an important
computation that then alters activity of reciprocally connected structures (Janak & Tye,
2015). Functionally, the BLA is implicated in forming associations between initially
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neutral stimuli with the outcomes they eventually predict, be they positive or negative,
and influencing behavioral responses to the cues (Janak & Tye, 2015). The central
nucleus of the amygdala (CeA) is an important subnucleus of the amygdala as its mostly
GABAergic cells receives dense input from the BLA and is viewed as an intermediary
between the BLA and behavioral responses (Janak & Tye, 2015). Importantly though, the
BLA and CeA have dissociable effects on both appetitive and aversive behaviors
(Killcross et al., 1997; Parkinson et al., 2000).
Early lesion studies in monkeys, rats, and humans identified the amygdala as a
key player in negative valence learning and memory (Adolphs et al., 1994; Anderson &
Phelps, 2001; Blanchard & Blanchard, 1972; S. Brown & Schafer, 1888; Cahill &
McGaugh, 1998; Janak & Tye, 2015; LeDoux et al., 1990; Quirk et al., 1995). One
powerful protocol used to investigate this is known as fear conditioning, which is when
animals are presented an conditioned stimulus (CS), often an auditory tone, that is
repeatedly paired with an unconditioned stimulus (US) such as a foot shock (Janak &
Tye, 2015; Phelps & LeDoux, 2005). Animals will form an association between the CS
and US, leading to defensive behavioral responses such as freezing in response to the CS
alone. During fear conditioning, BLA neurons will become active following CS onset and
the magnitude of their short-latency CS-evoked responses are enhanced (Janak & Tye,
2015; Quirk et al., 1995, 1997). The phenomenon that underlies this association is likely
Hebbian plasticity, wherein sensory inputs encoding both CS and US enter the BLA and
their coincidental activity enables the initially neutral CS to more strongly activate BLA
cells and elicit defensive responses alone (Hebb, 1949; Janak & Tye, 2015; Johansen et
al., 2010). Lesions in the BLA will block behavioral responding to the CS and CS-evoked
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increases in arterial pressure (Janak & Tye, 2015; LeDoux et al., 1984, 1990). In human
fear conditioning, functional magnetic resonance imaging revealed increased amygdala
activity (via blood-oxygen-level-dependent (BOLD) signal), the magnitude of which is
related to that of the conditioned response (Büchel et al., 1998; LaBar et al., 1998; Phelps
et al., 2004).
In addition to the rich body of literature on fear learning and the BLA, there is a
great deal of work indicating that this structure is also involved in reward learning
(Baxter & Murray, 2002; Gallagher et al., 1990; Hiroi & White, 1991; Janak & Tye,
2015; Jentsch & Taylor, 1999; Murray, 2007). Activating cyclic adenosine
monophosphate (cAMP)-dependent protein kinase A (PKA) in the amygdala of rats
enhanced reward learning as measured by conditioned approach behavior (Jentsch et al.,
2002). Lesions in the BLA impair amphetamine conditioned place preference but this
deficit is more complex than simply removing the rewarding qualities of reinforcers,
since self-administration of cocaine or food-cup approach behavior is not disrupted
(Baxter & Murray, 2002; Gallagher et al., 1990; Hiroi & White, 1991; Janak & Tye,
2015; Stamatakis et al., 2014). In other words, the BLA is not required for a drug or food
to be rewarding, since the animals will consume the drug and seek the food without a
functioning BLA. Instead, it has been suggested that the BLA is critical for linking
stimuli with their current value for an organism, which is informed by reinforcer
devaluation studies that find BLA lesioned animals will not modify behavior after eating
their fill of a particular treat, suggesting that the BLA is necessary for the animal to
change its behavior in light of the updated value of the treat (Baxter & Murray, 2002).
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Ablation of amygdala neurons that project to the orbitofrontal cortex impair the ability of
rats to modify strategies based on previous rewards (Groman et al., 2019).
At first it may appear puzzling that the BLA has been demonstrated to be
involved in both appetitive and aversive learning and memory. Perhaps one might have
assumed there would be distinct positive and negative centers in the brain, since they may
inherently feel like opposites to individuals. This apparent contradiction can be addressed
by remembering that the BLA is a group of non-homogenous cells projecting all across
the brain (Beyeler et al., 2018; Janak & Tye, 2015; J. Kim et al., 2016; Pignatelli &
Beyeler, 2019). Recent work has identified two populations of BLA neurons that are
genetically, spatially, and morphologically distinct that preferentially encode positive or
negative experiences (J. Kim et al., 2016). This study showed that cells expressing the
genetic markers, Rspo2 and Ppp1r1b, in the BLA were not only distributed along an
anterior-posterior gradient, but were also preferentially involved in negative or positive
valence behaviors, respectively. Being able to use readily accessible metrics like a
genetic marker or spatial segregation to determine the propensity of given BLA neurons
to be involved in an aversive or appetitive experience would be a powerful way to
compare how learning and memory of opposing valence may differ in the BLA. The
spatial segregation is contested by other groups, who instead report cells interspersed
throughout the BLA in more of a gradient, which was organized by the cells’ projection
target (Beyeler et al., 2018). Thus, it may be best to think of the BLA as capable of
encoding valence of both types, with particular groups of cells being biased to positive
and/or negative as well as population coding playing a role (Pignatelli & Beyeler, 2019).
Additionally, the interplay between appetitive and aversive memory may be even more
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intertwined because recent studies indicate that the absence of an expected aversive
reinforcer is rewarding and reward-related neurons are involved in extinguishing fear
memories (Felsenberg et al., 2018; Zhang et al., 2020).
Given that the BLA is involved in both appetitive and aversive memory (Beyeler
et al., 2018; Janak & Tye, 2015; J. Kim et al., 2016; Pignatelli & Beyeler, 2019) and ACh
is known to be released following reinforcers of both valence (Ballinger et al., 2016;
Hangya et al., 2015) it is worth considering how the two might interact. Indeed, the BLA
receives dense cholinergic input, especially from the BF (Ballinger et al., 2016; Picciotto
et al., 2012; Woolf, 1991). The investigation into BLA ACh signaling and learning and
memory is not new, as studies from almost 20 years ago showed impairments in fear
learning following lesions of BLA-projecting BF cholinergic neurons (Everitt & Robbins,
1997; Knox, 2016; Power et al., 2002) and recent technological advancements have
allowed even more detailed study (Aitta-aho et al., 2018; Ballinger et al., 2016; Jing et
al., 2018; Knox, 2016; Unal et al., 2015). While a more in depth description of the
improvements over previous techniques will follow in the relevant chapters, it is worth
pointing out some of the recent insight gained from the use of genetically targeted,
optogenetic manipulation of BLA-projecting cholinergic terminal fibers and the advent of
a genetically encoded fluorescent ACh sensor (Jing et al., 2018, 2020).
We do not have a full picture of how endogenous ACh affects the BLA because,
until recently, much of the work used exogenous cholinergic agonists like carbachol in
vitro, which, due to uniform bath application, might affect receptors differently than ACh
itself (Unal et al., 2015). While the complete story remains to be determined,
electrophysiological BLA recordings combined with optogenetically-evoked endogenous
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ACh release has brought us several important steps closer (Aitta-aho et al., 2018; Jiang et
al., 2016; Unal et al., 2015). Patch-clamp recordings in vitro illustrated how ACh
signaling influenced various BLA cell types (Unal et al., 2015). Late firing interneurons
were shown to be quickly excited through nicotinic receptors while fast-spiking
interneurons were unresponsive to ACh release. Via M1 AChRs, principal neurons that
were more active at the time of ACh release were found to have a net excitatory effect,
due to a prolonged afterdepolarization while quiescent neurons were inhibited following
increased inward potassium conductance (Unal et al., 2015). However, another study
found that BLA principal neuron firing was increased after optically-evoked ACh release
regardless of current activity level (Jiang et al., 2016). The authors offered differences in
stimulation pattern or recording approach as an explanation, but interestingly they also
reported involvement of nAChRs, but not mAChRs, in this ACh-mediated excitation.
This group also found increases in BLA principal cell firing rate following stimulation of
cholinergic terminal fibers during in vivo recordings. Additionally, the authors reported
enhanced glutamatergic release from afferents in the BLA as well as induction of LTP
following evoked ACh release, suggesting a role for ACh to potentiate learning through
multiple avenues in the BLA (Jiang et al., 2016). Lastly, another group of researchers
looked at changes in synchronous oscillations in the BLA following stimulation of
cholinergic BF cell bodies and found increases in theta and gamma power that were at
least partly dependent on AChRs, because AChR antagonism occluded some of the
increases in power observed (Aitta-aho et al., 2018). Theta and gamma range synchrony
between the BLA and interconnected areas coincides with emotional memory processes
(Bocchio et al., 2017). Technological barriers to directly measuring ACh release on sub-
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second timescales limited the temporal precision of conclusions that could be drawn
between the interaction of stimuli and ACh release (Sarter et al., 2016). The development
of genetically encoded fluorescent ACh sensor (Jing et al., 2018, 2020) opens the door
for relatively easy, direct investigation of ACh release in the BLA.
Taking advantage of these new techniques and a substantial body of literature
pointing to ACh signaling in the BLA being important for emotionally charged learning
and memory, I will present data of the recording and manipulation of cholinergic
signaling in the BLA during an appetitive learning task. Chapter 2 describes the
development of the cue-reward learning task used throughout this dissertation, in which
mice learned to nose poke in response to an auditory tone to earn a food reward. Chapter
3 covers fiber photometric recordings during reward learning of BLA ACh signaling
directly using the ACh sensor, BF cholinergic terminal fiber activity in the BLA, and the
activity of BLA principal neurons. Chapter 4 details studies of optogenetic and
pharmacological manipulation of cholinergic signaling and the enhancement or
impairment of learning.
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2. Chapter 2: Cue-reward learning task development
Portions of this chapter have been published in:
Crouse, Richard B, Kristen Kim, Hannah M Batchelor, Eric M Girardi, Rufina
Kamaletdinova, Justin Chan, Prithviraj Rajebhosale, et al. “Acetylcholine Is
Released in the Basolateral Amygdala in Response to Predictors of Reward and
Enhances the Learning of Cue-Reward Contingency.” eLife 9 (September 18,
2020): e57335.

Introduction
In order to study the effects of cholinergic signaling in the BLA on appetitive
learning, I needed to validate a behavioral task that engaged the BLA. Given the BLA’s
role in associating initially neutral cues with the salient stimuli they predict (Janak &
Tye, 2015; Taylor et al., 2009), it was clear that any task we chose should employ cues
that predict reward availability. However, previous literature indicated that many types of
stimulus-reward learning are amygdala independent (Baxter & Murray, 2002; Murray,
2007). We opted to use an operant task instead of classical conditioning in order to have
access to a larger number of data points linked to responses and outcomes, beyond
reward approach or orienting. Since we were interested in how cholinergic signaling was
involved across all phases of learning, a task that required several weeks of training could
unnecessarily complicate analysis. However, very simple operant tasks, such as fixed
ratio 1 paradigms, are not affected by BLA inactivation (Ambroggi et al., 2008; Ishikawa
et al., 2008). Thus, we took inspiration from previous work in our lab (Horst et al., 2012)
and others (Ambroggi et al., 2008), to design a cue-reward learning task that requires
mice to nose poke when they hear a tone in order to receive reward.
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Materials and Methods
Behavioral Testing
All procedures were approved by the Yale University Institutional Animal Care &
Use Committee (protocol: 2019-07895) in compliance with the National Institute of
Health’s Guide for the Care and Use of Laboratory Animals. Experiments were
performed in mice of both sexes, in keeping with the NIH policy of including sex as a
biological variable. Sex of mice in behavioral graphs is indicated by circles for females
and squares for males.
Mice were weighed daily and given sufficient food (2018S standard chow,
Envigo, Madison, WI) to maintain 85% free-feeding body weight between 4-6 PM
throughout the course of the cue-reward learning task. All behavioral tests were
performed during the light cycle, typically beginning at 7 AM and ending before 1 PM.
Mice were allowed to acclimate to the behavioral room for 30 min before testing and
were returned to the animal colony after behavioral sessions ended.
A week after starting food restriction, mice were handled 3 min per day for 7 days
in the behavioral room. Mice were given free access to the reward (EnsurePlus Vanilla
Nutrition Shake solution mixed with equal parts water (Ensure); Abbott Laboratories,
Abbott Park, IL) in a 50 mL conical tube cap in their home cages on the last 3 days of
handling to familiarize them to the novel solution.
Operant training was carried out using Med Associates modular test chambers and
accessories (ENV-307A; Med Associates Inc., Georgia, VT) inside sound attenuating
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chambers (ENV-022M). Two nose poke ports (ENV-313-M) were placed on the left wall
of the chamber and the reward receptacle (ENV-303LPHD-RL3) was placed on the right
wall. The receptacle cup spout was connected to a 5 mL syringe filled with Ensure loaded
in a single speed syringe pump (PHM-100). Nose pokes and receptacle entries were
detected by infrared beam breaks. The tone generator (ENV-230) and speaker (ENV224BM) were placed outside the test chamber, but within the sound attenuating chamber,
to the left. The house light (used for timeout, ENV-315M) was placed on top of the tone
generator to avoid snagging patch cords. Each chamber had a fan (ENV-025F28) running
throughout the session for ventilation and white noise. Behavior chambers were
connected to a computer running MEDPC IV to collect event frequency and timestamps.
Each mouse was pseudo-randomly assigned to behavioral chamber when multiple
chambers were used, counterbalancing for groups across boxes.
After the week of handling, initial operant familiarization consisted of one 35 min
session of Free Reward to demonstrate the location of reward delivery; all other sessions
were 30 mins. During Free Reward, only the reward receptacle was accessible. After 5
min of habituation, Ensure (24 µL over 2 seconds) was delivered in the receptacle cup
and a light was turned on above the receptacle. The receptacle light was turned off upon
receptacle entry. The next phase of operant familiarization, mice learned to nose poke to
receive reward on a fixed-ratio one (FR1) schedule of reinforcement. Mice in
experiments involving manipulations (optical stimulation and antagonist studies) were
pseudo-randomly assigned to left or right active (reinforced) nose poke port. Mice in
fiber photometry experiments were all assigned to right active port to minimize potential
across subject variability. The inactive (unreinforced) port served as a locomotor control.
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During FR1 operant familiarization, each nose poke response into the active port resulted
in receptacle light and reward delivery.
After the mice reached criterion on FR1 operant familiarization (group average of
30 rewards for 2 consecutive days, usually 4-5 days), mice were advanced to the PreTraining phase. This phase incorporated an auditory tone (2.5-5 kHz, ~60 dB) that lasted
for at most 10 seconds and signaled when active nose pokes would be rewarded. Only
active nose pokes made during the 10 sec auditory tone (correct nose pokes) resulted in
reward and receptacle light delivery. The tone co-terminated with Ensure delivery.
During Pre-Training, there was no consequence for improper nose pokes, neither in the
active port outside the tone (incorrect nose pokes) nor in the inactive port (inactive nose
pokes). The number of inactive nose pokes were typically very low after operant
familiarization and were not included in analysis. After reward retrieval (receptacle entry
following reward delivery) the receptacle light was turned off and the tone was presented
again on a variable intertrial interval schedule with an average interval of 30 sec (VI 30),
ranging from 10 to 50 sec (Ambroggi et al., 2008).
After 4-5 days of Pre-Training, mice progressed to the Training phase, which had
the same contingency as Pre-Training except incorrect nose pokes resulted in a 5 sec
timeout signaled by house light illumination, followed by a restarting of the previous
intertrial interval. Mice were considered to have acquired the task after earning 20
rewards during the Training phase of the task. Mice progressed to Extinction after 12
days of Training. Extinction was identical to Training except no Ensure was delivered in
response to correct nose pokes.
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Between mice, excrement was removed from the chambers with a paper towel. At
the end of the day chambers were cleaned with Rescue Disinfectant (Virox Animal
Health, Oakville, Ontario, Canada) and Ensure syringe lines were flushed with water then
air. Mice were excluded from analyses if a behavioral chamber malfunctioned (e.g.
syringe pump failed).

Results
We designed a cue-reward learning task in which food-restricted mice were
trained 30 min per day to perform a nose poke when signaled by a cue (tone) to receive a
palatable reward (Ensure) on a 30 sec variable intertrial interval (ITI) (Figure 2.1-Figure
2.3).

Figure 2.1. Cue-reward learning behavioral chamber setup. A) Mice were placed in
modular test chambers that included two nose poke ports on the left wall (Active and
Inactive) and the Reward Receptacle on the right wall. A tone generator and timeout light
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were placed outside the modular test chamber. For fiber photometry (FP) and optical
stimulation (Laser) experiments, mice were tethered to a patch cord(s).

During the Pre-Training phase of the task, mice received reward and cue light
presentation for performing a nose poke in the active port during tone presentation
(Figure 2.3C, purple active nose poke coincident with tone) but there was no
consequence for an incorrect nose poke (Figure 2.3C, red active nose poke not coincident
with tone). The Training phase of the task was identical to Pre-Training except incorrect
nose pokes resulted in a 5 sec timeout, during which the house light was illuminated, that
concluded with a restarting of the ITI timer (Figure 2.3C, red active nose poke not
coincident with tone).
Initial piloting of the task showed that mice increased number of rewards earned
over the course of a few days during Pre-Training, eventually plateauing by day 4 (Figure
2.2C, blue shaded region). However, mice made roughly five-fold more incorrect nose
pokes than rewards earned and after 3 days past the reward plateau, the mice showed
little sign of decreasing the incorrect nose pokes (Figure 2.2D, blue shaded region). This
suggested that the mice were not attending to the contingency of the task, i.e. that they
should not nose poke when the tone is not present. In order to promote adherence to task
contingency, we progressed mice to the Training phase, where their incorrect nose pokes
resulted in a 5 sec timeout (Figure 2.2C-D, pink shaded region). As mice adapted to the
new phase of the task, they again earned more rewards of several days but this time,
decreased incorrect nose poking. We noticed that after mice crossed a threshold of around
20 rewards during Training their behavior generally continued to improve. Thus, we
considered the acquisition threshold to be 20 rewards, which occurred for the cohort
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average after 6-7 days of Training (Figure 2.2C, white horizontal line). After 14 days of
Training, mice progressed to the Extinction phase, which was identical to Training,
except they no longer received reward for correct nose pokes (Figure 2.2C-D, orange
shaded region). Rewards earned quickly dropped when Ensure was not actually delivered
and the number of incorrect nose pokes remained minimal.
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Figure 2.2. Cue-reward learning paradigm piloting. A-B) Details of the cue-reward
learning paradigm A) In Pre-Training, an auditory tone was presented on a variable
interval 30 schedule (VI30), during which an active nose poke yielded Ensure reward
delivery but there was no consequence for incorrect nose pokes (active nose pokes not
during tone). B) Training was identical to Pre-Training, except incorrect nose pokes
20

resulted in a 5 sec timeout, signaled by timeout light illumination, followed by a
restarting of the intertrial interval (ITI) C-D) Pilot behavioral testing shows rewards
earned will plateau during PT (blue shaded region) but mice will not decrease incorrect
nose poking until Training (pink shaded region), when incorrect nose pokes result in a 5
sec timeout. Mean ± SEM, n = 4. C) Rewards earned. Horizontal white line: acquisition
threshold, when a mouse began to earn ~20 rewards consistently in Training. D) Incorrect
nose pokes.

Based on this pilot cohort, we believed this paradigm would not be too difficult
for mice to acquire and provided ample behavioral dynamic range for employing
interventions that aimed to improve or impair learning. However, this initial cohort
underwent extensive appetitive and aversive valence testing, thus we wanted to determine
the learning profile of naïve mice. We decreased the number of Pre-Training and
Training sessions (Figure 2.3A) and found similar results with an independent cohort of
mice (Figure 2.3B-C). There was some variability in sessions required for this cohort to
reach acquisition criterion (8-9 days) compared to the previous cohort (6-7 days) and
there were nearly twice as many incorrect nose pokes made by the naïve cohort. To
control for cohort differences, we always include a control group for each experiment.
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Figure 2.3. Final experimental timeline and baseline behavior. A) Experimental
timeline. Mice began food restriction 7 days after surgery (when applicable) and were
maintained at 85% free-feeding body weight for the duration of the experiment. After 7
days of handling, 5-6 days of operant familiarization prepared the mice for the cuereward learning task (Pre-Training through Extinction). B-C) Mice will typically acquire
the task after 8-9 days of Training. Note, these are the control group are from a larger
experiment shown in Figure 4.6. Mean ± SEM, n = 8. B) Rewards earned. Horizontal
white line: acquisition threshold. C) Incorrect nose pokes.
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Discussion
The cue-reward learning task described here will be used in the following
chapters. Since we have 12 operant boxes and training sessions were only 30 min each
day, once the task parameters were optimized, we had the ability to run multiple
experiments simultaneously. We found this task to be a robust and replicable way to
measure appetitive learning. Previous literature gave us reason to believe that the BLA
would be engaged during this task (Ambroggi et al., 2008; Baxter & Murray, 2002;
Ishikawa et al., 2008), especially because our presentation of an auditory tone separated
by intertrial intervals that varied from 10-50 sec has been shown to strongly excite BLA
neurons (Collins & Paré, 2000; Herry et al., 2007), unlike solely fixed-ratio 1 tasks that
do not require the BLA (Ambroggi et al., 2008; Ishikawa et al., 2008).
Throughout the course of the task, two distinct response patterns emerged:
animals that earn many rewards but are not selective in their responding (such as in PreTraining) and those that earn many rewards and refrain from excessive nose poking (as in
Training after acquisition). When recording ACh signaling or calcium dynamics, this
allows us to distinguish between the effect of earning rewards in the presence of a tone
and earning rewards when animals appear to be attending to the tone and using it to guide
behavior. However, it is important to note that this shift in behavioral pattern was only
observed when incorrect nose pokes resulted in timeouts. The food restricted mice are
only trained 30 min a day, so being in timeout might be viewed as negative or punishing
because they are not able to earn food reward during that time. Whether or not mice do
23

interpret the timeout period and/or the house light that signals a timeout as aversive
remains to be determined. Additionally, it is possible the shift in behavioral pattern and
apparent attention to task contingency is guided by mice learning to withhold incorrect
nosepokes because of this possibly aversive timeout (and/or its cue) rather than the
reward for correctly nose poking, but this also remains to be determined.
This task also allows us to measure how manipulations in cholinergic signaling
during learning affect not only the acquisition of the task, but also the extinction of
responding. This is important because extinction is not simply forgetting, but is instead
active, new learning (Millan et al., 2011; Taylor et al., 2009), which may reveal patterns
distinct from initial acquisition. Further, recordings during extinction also allow us to
observe changes in ACh signaling or cell activity when reinforcement is omitted and the
value of the CS diminishes.
Overall, this cue-reward learning paradigm serves as a way to record or
manipulate cholinergic signaling in the context of appetitive learning.
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3. Chapter 3: Basolateral amygdala cholinergic signaling and principal cell
activity during reward learning
Portions of this chapter have been published in:
Crouse, Richard B, Kristen Kim, Hannah M Batchelor, Eric M Girardi, Rufina
Kamaletdinova, Justin Chan, Prithviraj Rajebhosale, et al. “Acetylcholine Is
Released in the Basolateral Amygdala in Response to Predictors of Reward and
Enhances the Learning of Cue-Reward Contingency.” eLife 9 (September 18,
2020): e57335.

Introduction
The ability of ACh to exert control over large groups of neurons throughout the
brain and its role in many critical brain functions has motivated many researchers to
understand cholinergic signaling. However, because ACh is a neuromodulator that
interacts with both excitatory and inhibitory neurons through a wide range of AChRs that
are active across a range of timescales, it is difficult to simply record from recipient cells
to determine when ACh was released, as you might for a neurotransmitter like glutamate
(Ballinger et al., 2016; Picciotto et al., 2012).
Microdialysis is one strategy to investigate ACh signaling in vivo. In
microdialysis studies a probe encased in a semipermeable membrane is inserted into the
brain region of interest and diffusion of small molecules in the extracellular space across
the membrane allows detection and quantitation (König et al., 2018). This approach can
be used to detect changes in ACh concentration and has been employed during many
different types of behavior, but its temporal resolution is quite low, on the order of
several minutes, which limits the types of observations that can be made (Ballinger et al.,
2016; König et al., 2018). Electrochemistry has improved temporal resolution over
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microdialysis at the cost of direct ACh measurement, because most versions detect
choline, a byproduct of ACh catalysis (Burmeister & Gerhardt, 2003; Parikh et al., 2004,
2007). Utilization of electrochemistry allowed indirect detection of rapid ACh release in
a way that was impossible with microdialysis and paved the way for additional ways to
think about ACh signaling (Ballinger et al., 2016; Parikh et al., 2007; Sarter et al., 2016).
However, electrochemical probes require an enzymatic coating that presents stability and
reproducibility concerns, as well as a high threshold of detection (Schuvailo et al., 2005).
With the development of fluorescent sensors for other neurotransmitter systems and
calcium (Chen et al., 2013; Hires et al., 2008; Marvin et al., 2013), many researchers
hoped that ACh signaling would eventually be able to be measured this way.
Recently, a genetically encoded fluorescent ACh sensor was developed that is
suitable for in vivo detection (Jing et al., 2018, 2020). The GRABACh3.0 (referred to as
ACh3.0 moving forward) sensor is a chimeric mAChR in which the intracellular domain
that usually allows coupling to G-proteins has been exchanged for a conformationallysensitive form of green fluorescent protein (GFP). This is important because when ACh
binds to the receptor, it leads to a conformational change, inducing the GFP to fluoresce
more intensely. In short, if the concentration of ACh increases near the sensor, it binds to
the agonist site in the mAChR, leading to an allosteric transition, and fluorescence
increases. The ACh3.0 biosensor can be packaged into an adeno-associated virus and
infused into a brain area of interest, such as the BLA. Biosensor infusion can then be
paired with a fiber photometric recording system, in which an optical fiber is implanted
over the BLA, to measure changes in ACh release for months in the same animal
(Gunaydin et al., 2014; Jing et al., 2020).
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Given the limitations of other methodologies, the appeal of using a sensor like
ACh3.0 is apparent for studying cholinergic release in the BLA during learning. Using
this technique, changes in ACh release can be measured in response to multiple aspects
of the behavioral task before, during, and after learning. However, like other ACh
measurement techniques, detection of release will not report which brain area(s) are
contributing the ACh. The BF, particularly the nucleus basalis of Meynert (NBM), is a
likely candidate for the source of ACh release in the BLA (Ballinger et al., 2016;
Picciotto et al., 2012; Woolf, 1991). Infusing a viral construct encoding a Cre-dependent
calcium sensor into the NBM of a transgenic mouse line in which cholinergic cells
express Cre-recombinase, along with an optical fiber placed above the BLA, allows for
recording from the terminals of cholinergic NBM neurons that project to the BLA (NBMBLA). Identifying the brain area that provides the ACh input to BLA will be necessary to
carry out manipulations of endogenous ACh release, in order to move past observation of
release patterns, to determining whether ACh signaling contributes to learning.
Just as using ACh3.0 in BLA won’t reveal where the ACh is coming from, it will
also not reveal how the activity of postsynaptic cells is affected by ACh signaling. Since
the BLA is a complex network of many different cell types that influence each other’s
activity (Beyeler & Dabrowska, 2020; Janak & Tye, 2015), recording from multiple cell
types would be necessary to understand the full impact of ACh signaling. Glutamatergic
principal neurons are the primary output cells of the BLA and they are known to be
involved in encoding both positive and negative memories, making them an ideal target
for recording the overall outcome of cholinergic signaling. Calcium/calmodulindependent protein kinase (CaMKII) has been shown to be a marker for glutamatergic
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BLA principal cells (Butler et al., 2011; Felix-Ortiz & Tye, 2014; McDonald, 1992; Tye
et al., 2011). Therefore, one way to evaluate the output of the BLA across phases of
learning is to infuse a Cre-dependent calcium sensor into the BLA of a CaMKII-Cre
mouse line and implant an optical fiber above the structure to record principal neuron
activity during the behavioral task.
In this chapter, I report the findings from studies of fiber photometry recordings
of 1) ACh signaling, 2) cholinergic NBM-BLA terminals and, 3) BLA principal cells. I
performed these recordings while mice learned to nose poke following an auditory tone
in order to earn a food reward to determine how ACh dynamics and cell activity changed
across the development of appetitive learning. We hypothesized that there would be ACh
transients following tone onset after acquisition of the task (Parikh et al., 2007).
Additionally, we hypothesized that the time course of cholinergic NBM-BLA cell activity
would be similar to the measured ACh transients. Finally, we also expected that BLA
principal neurons would become excited following tone onset once animals learned to
associate the tone with reward.

Materials and Methods
Animals
All procedures were approved by the Yale University Institutional Animal Care &
Use Committee (protocol: 2019-07895) in compliance with the National Institute of
Health’s Guide for the Care and Use of Laboratory Animals. Experiments were
performed in mice of both sexes, in keeping with the NIH policy of including sex as a
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biological variable. Sex of mice in behavioral graphs is indicated by circles for females
and squares for males.
Female and male heterozygous mice with Cre recombinase knocked into the
choline acetyltransferase (ChAT) gene (ChAT-IRES-Cre, B6;129S6-Chattm2(cre)Lowl/J,
Jackson Laboratory, Bar Harbor, ME) were bred in house by mating ChAT-IRES-Cre
with C57BL6/J mice. CaMKIIα-Cre (Tg(Camk2a-cre)2Gsc) mice obtained from Ronald
Duman (Casanova et al., 2001; Wohleb et al., 2016) were bred in house as above.
C57BL6/J mice were obtained from The Jackson Laboratory and tested at 5-7 months of
age, following at least one week of acclimation. All mice were maintained in a
temperature-controlled animal facility on a 12-hour light/dark cycle (lights on at 7:00
AM). Mice were group housed 3-5 per cage and provided with ad libitum food and water
until undergoing behavioral testing. Mice were single housed 1-3 weeks before surgery to
facilitate food restriction and body weight maintenance.

Surgical procedures
Surgical procedures for behavior were performed in fully adult mice at 4-6
months of age, age-matched across conditions. For viral infusion and fiber implantation,
mice were anesthetized using isoflurane (induced at 4%, maintained at 1.5-2%) and
secured in a stereotactic apparatus (David Kopf Instruments, Tujunga, CA). The skull
was exposed using a scalpel and Bregma was determined using the syringe needle tip (2
µL Hamilton Neuros syringe, 30 gauge needle, flat tip; Reno, NV).
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For fiber photometry surgeries, 0.4 µL of AAV9 hSyn-ACh3.0 (Vigene
Biosciences Inc., Rockville, MD) to measure BLA ACh levels was delivered unilaterally
to the BLA (A/P; -1.34 mm, M/L + or - 2.65 mm, D/V -4.6 mm, relative to Bregma) of
ChAT-IRES-Cre or wild-type C57BL6/J mice at a rate of 0.1 µL/min. The needle was
allowed to remain at the infusion site for 5 min before and 5 min after injection. A mono
fiber-optic cannula (1.25 mm outer diameter metal ferrule; 6 mm long, 400 µm core
diameter/430 µm outer diameter, 0.48 numerical aperture (NA), hard polymer cladding
outer layer cannula; Doric Lenses, Quebec City, Quebec, Canada) was implanted above
the BLA (A/P; -1.34 mm, M/L + 2.65 mm, D/V -4.25 mm) and affixed to the skull using
opaque dental cement (Parkell Inc., Edgewood, NY). For BLA CaMKIIα cell calcium
dynamic recordings, 0.5 µL of AAV1 Syn-FLEX-GCaMP6s-WPRE-SV40 (Addgene,
Watertown, MA) was injected into the left BLA using the same procedure and
coordinates but was injected into CaMKIIα-Cre mice. Cholinergic NBM-BLA terminal
fiber calcium dynamic recording surgeries were performed as above except AAV1-SynFLEX-jGCaMP7s-WPRE (Addgene) was infused unilaterally into the NBM (A/P: - 0.7
mm, M/L + or - 1.75 mm, D/V – 4.5 mm) of ChAT-IRES-Cre mice, with the optical fiber
being placed above the ipsilateral BLA. The jRCaMP1b + ACh3.0 surgeries to
simultaneously measure cholinergic NBM-BLA terminal fiber calcium dynamics and
BLA ACh levels consisted of both the NBM and BLA infusions above, except AAV1
Syn-FLEX-NES-jRCaMP1b-WPRE-SV40 (Addgene) was infused the NBM of ChATIRES-Cre mice. The RCaMP sham mouse was a wild-type littermate and thus had no
jRCaMP1b expression. pAAV.Syn.Flex.GCaMP6s.WPRE.SV40 (Addgene viral prep #
100845-AAV1; http://n2t.net/addgene:100845 ; RRID:Addgene_100845), pGP-AAV-
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syn-FLEX-jGCaMP7s-WPRE was a gift from Douglas Kim & GENIE Project (Addgene
viral prep # 104491-AAV1; http://n2t.net/addgene:104491 ; RRID:Addgene_104491),
and pAAV.Syn.Flex.NES-jRCaMP1b.WPRE.SV40 (Addgene viral prep # 100850AAV1; http://n2t.net/addgene:100850 ; RRID:Addgene_100850) were gifts from
Douglas Kim & GENIE Project (Chen et al., 2013; Dana et al., 2016, 2019).
Mice were allowed to recover in a cage without bedding with a microwavable
heating pad underneath it until recovery before being returned to home cage. For two
days following surgery, mice received 5 mg/Kg Rimadyl i.p (Zoetis Inc., Kalamazoo,
MI) as postoperative care.

Behavioral Testing
Behavioral testing was carried out as described in Chapter 2, with the
modifications below.
Initial BLA ACh3.0 and BLA CaMKIIα GCaMP6s fiber photometry recordings
occurred in a darkened behavioral room outside of sound attenuating chambers (ENV022M) due to steric constraints with rigid fiber photometry patch cords. Later behavioral
chamber optimization (wall height was extended with 3D printed and laser cut acrylic
panels to allow removing the test chamber lid while preventing escape) allowed all other
fiber photometry cohorts to be tested inside sound attenuating chambers by drilling a hole
in the top of the chambers to allow the patch cord to pass through. A custom receptacle
was 3D printed that extended the cup beyond the chamber wall to allow mice to retrieve
the reward with more rigid patch cords used for fiber photometry experiments.
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In order to promote task acquisition, mice that were not increasing number of
rewards earned reliably were moved to a VI 20 schedule after 9 days of VI 30 Training
for BLA ACh3.0 or 6-7 days for BLA CaMKIIα GCaMP6s mice. The VI 20 schedule
was only needed for the two groups that were trained outside of the sound attenuating
chambers. Mice in the initial fiber photometry cohorts progressed to Extinction once all
mice met the acquisition criteria. The replicate cohorts of the BLA CaMKIIα GCaMP6s
and NBM-BLA terminal fiber recording experiments were advanced to one day of
Extinction after only 7 days of Training due to the COVID-19 shutdown. Mice were
excluded from analyses if they did not meet the acquisition criterion by the last day of
Training. See Appendix 1 for number of mice that acquired, were excluded, and further
explanations for behavioral paradigm deviations.
Cued fear conditioning was performed outside of a sound attenuating chamber in
the right compartment of a Med Associates modular shuttle box (ENV-010MC) equipped
with a grid floor. The mice underwent 3 days of conditioing: baseline, fear conditioning,
and recall. All conditioning sessions were 18 min long, broken into 3 min bins. The first
bin was habituation, where no stimuli were delivered. Each of the remaining bins
consisted of a 5 sec auditory tone that was presented after a random delay period. The
tone used (4 KHz) was disctinct from the one use for cue-reward learning (2.5 KHz for
this cohort). Only on the fear conditioning day, the tone was paired with a 1 sec, 0.4 mA
footshock that co-terminated with the tone. Similar to the cue-reward learning task, TTL
pulses synchronized the Med Associates program with the fiber photometry rig.

Fiber Photometry Data Acquisition
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Fluorescent measurements of ACh and calcium levels were recorded using two
Doric Lenses 1-site Fiber Photometry Systems: a standard 405/465 nm system and a
405/470/560 nm system. The standard 405/465 system was configured as follows: the
fiber photometry console controlled the two connectorized LEDs (CLEDs, 405 nm
modulated at 208.616 Hz and 465 nm modulated at 572.205 Hz) through the LED
module driver (Cassidy et al., 2019). Each CLED was connected via attenuating patch
cord to the five-port Fluorescence MiniCube (FMC5_AE(405)_AF(420-450)_E1(460490)_F1(500-550)_S). A pigtailed fiber optic rotary joint was connected to the MiniCube
and suspended above the behavioral chamber with a rotary joint holder in order to deliver
and receive light through the implanted optical fiber. The other end of the rotary joint was
connected to the mono fiber optic patch cord via M3 connector and attached with a
zirconia sleeve to the implanted fiber optic as above. The F1 (500-550 nm) port of the
MiniCube was connected to the photoreceiver (AC low mode, New Focus 2151 Visible
Femtowatt Photoreceiver, New Focus, San Jose, CA) via a fiber optic adapter (Doric
Lenses) that was finally connected back to the fiber photometry console through an
analog port. The 405/470/560 nm system was set up similarly, except a 560 nm LED was
incorporated (modulated at 333.786 Hz), a six-port MiniCube with two integrated
photodetector heads was used (iFMC6_IE(400-410)_E1(460-490)_F1(500-540)_E2(555570)_F2(580-680)_S), and Doric Fluorescence Detector Amplifiers were used (AC 1X or
10X mode, DFD_FOA_FC). A TTL adapter (SG-231, Med Associates Inc.) was
connected to the digital input/output port to allow for timestamping when events occurred
in the behavioral chamber. Signal was recorded using Doric Neuroscience Studio (V
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5.3.3.14) via the Lock-In demodulation mode with a sampling rate of 12.0 kS/s. Data
were decimated by a factor of 100 and saved as a comma-separated file.

Fiber Photometry Data Pre-Processing
Preprocessing of raw data was performed using a modified version of a MATLAB
(MathWorks, Natick, MA) script provided by Doric. The baseline fluorescence (F0) was
calculated using a first order least mean squares regression over the ~30 min recording
session. Second order least mean squares regressions were used when photobleaching of
the sensor was more pronounced, as in the case of NBM-BLA terminal fiber recordings.
The change in fluorescence for a given timepoint (ΔF) was calculated as the difference
between it and F0, divided by F0, which was multiplied by 100 to yield %ΔF/F0. The
%ΔF/F0 was calculated independently for both the signal (465 nm) and reference (405
nm) channels to assess the degree of movement artifact. Since little movement artifact
was observed in the recordings, the signal %ΔF/F0 was analyzed alone (the entire
analysis pipeline was run with the reference channel %ΔF/F0 if desired). The %ΔF/F0
was z-scored to give the final Z%ΔF/F0 reported here. For the BLA CaMKIIα cell
recordings, the reference channel displayed some mirroring (moving in the opposite
direction) compared to the signal. This is likely because 405 nm is not the “true”
isosbestic point for GCaMP and we were instead measuring some changes in calciumunbound GCaMP rather than calcium-insensitive GCaMP signal alone (Barnett et al.,
2017; C. K. Kim et al., 2016; Sych et al., 2019). Graphs and heatmaps for averaged traces
aligned to actions were based on licking bout epoch filtering code from TDT (Alachua,
FL).
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Heatmaps
Combined event heatmaps were generated in MATLAB (2020a) by analyzing
data 5 sec preceding tone onset (rewarded trials only) to 5 sec after receptacle entry.
Actions were aligned despite variable latencies by evenly splitting a maximum of 4 sec
post-tone onset/pre-correct nose poke and 1 sec post-correct nose poke/pre-receptacle
entry for each trial within a day. The resulting aligned trials were averaged to generate
daily averages that made up the rows of the individual animal heatmaps. Blanks in the
rows of heatmaps (black time bins) indicate time bins added for alignment, meaning that
no trials for that day had a latency that stretched the entire window. Only rewarded trials
where the mouse entered the receptacle within 5 sec after nose poke were analyzed. Full
or partial training days were excluded from analysis if there were acquisition issues such
as the patch cord losing contact with the fiber or behavioral apparatus malfunction. Lack
of trials (fewer than three) for analysis or recording issues led to missing rows of fiber
photometry data in the heatmap despite having behavioral data, in which case these rows
were skipped rather than adding entire blank rows. Due to individual differences in
behavior, across-mouse average data was calculated by using a selection of days in which
behavior was roughly similar or milestones such as first and last day of Pre-Training, first
day earning 10 rewards in Training, first day crossing acquisition threshold (and
maintaining afterward), last day of Training, last day of Extinction (with 3 or more
rewarded trials that met analysis criteria). Additional days were included in across-mouse
average heatmaps when possible. Incorrect nose poke heatmaps were generated by
averaging signals for 5 sec before and 5 sec after incorrect nose pokes that were not
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preceded by an incorrect nose poke in the last 5 sec. The incorrect nose poke heatmaps
averaged across mice were generated using the same selection of days as the combined
event heatmaps for a given experiment.

Bootstrapped Confidence Interval Analyses
Bootstrapped Confidence Intervals (bCIs) of the Z-scored % ΔF/F0 fiber
photometry data within and across mice were generated using the methods described in
(Jean-Richard-dit-Bressel et al., 2020) for the following events: tone onset, correct nose
poke, receptacle entry, and incorrect nose poke. For the within-mouse analysis by day,
trials were aligned to event onset, and bCIs were generated for events that had at least 3
trials from 5 seconds prior to 10 seconds after each event. Each series of data were
bootstrapped 10,000 times and a two-sided 99% confidence interval was constructed.
Data were considered significantly different from baseline (Z% ΔF/F0 = 0) when their
99% bCIs did not contain zero for an interval of time designated by a consecutive
threshold of 0.5 sec.
To avoid comparing vastly different numbers of trials, in graphs where correct
and incorrect nose pokes were plotted together, incorrect nose pokes were downsampled
to match the number of correct nose poke trials. For Incorrect Nose Pokes graphs where
last Pre-Training Day and Training Day 1 were plotted together, both days were
downsampled to the number of correct nose pokes on the last Pre-Training Day.
For the combined event bCI plots (tone onset, correct nose poke, and receptacle
entry), the selection of days for each mouse matched that of the cohort-averaged
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combined event heatmaps. The three event plots were combined by cropping to match the
maximum latencies used in the combined event heatmaps. For the across-mouse averaged
bCI plots, analyses were carried out as above except the bootstrapping used mouse trial
averages. The mean lines for across-mouse averaged bCI plots were calculated by taking
the mean of all individual trials together. The NBM-BLA cholinergic terminal fiber
experiment required combining the two independent cohorts to obtain n ≥ 3. For the
incorrect nose poke bCI plots, the number of trials used for each day were downsampled
to 20 if a mouse performed more than 20.
Fear conditioning ACh3.0 bCIs were generated as above, except the Z% ΔF/F0
for 7 sec before and 8 sec after tone onset was analyzed but trimmed to only include 2 sec
before tone onset for visualization purposes. In the individual day plots, for each tone the
data from all mice were averaged together for bootstrapping (n = 4 for each tone). In the
day averaged plot, the across-mouse data for all tones in a day were averaged together for
bootstrapping (n = 5 for each day).

Histology
After completion of behavioral experiments, animals were anesthetized with 1X
Fatal-Plus (Vortech Pharmaceuticals). Once there was no response to toe-pinch, mice
were transcardially perfused with 20 mL ice cold 1X DPBS followed by 20 mL 4%
paraformaldehyde (PFA, Electron Microscopy Sciences, Hatfield, PA). Brains were
extracted and post-fixed for at least 1 day in 4% PFA at 4°C and transferred to 30%
sucrose (Millipore Sigma) for at least 1 day at 4°C. Brains were sliced 40 µm thick on a
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self-cooling microtome and stored in a 0.02% sodium azide (Millipore Sigma) PBS
solution. Brain slices were washed in PBS, blocked for 2-3 hours (0.3% Triton X-100,
American Bioanalytical, Canton, MA; 3% normal donkey serum, Jackson
ImmunoResearch, West Grove, PA), then incubated overnight with primary antibodies
(1:1000 + 1% normal donkey serum). Slices were then washed in PBS and incubated
with secondary antibodies (1:1000) for 2 hours, washed, stained with DAPI for 5 min,
washed, mounted, and coverslipped with Fluoromount-G (Electron Microscopy
Sciences). All incubations were at room temperature. Microscope slides were imaged
using a FLUOVIEW FV10i confocal microscope (Olympus). Injection sites and fiber
placements were designated on modified Allen Mouse Brain Atlas figures (Lein et al.,
2007). Mice were excluded from analyses if fluorescence was not observed at injection
sites or if fiber tips were not identified at the intended site.

Results
Acetylcholine release in the BLA occurs at salient points in the cue-reward learning
task and shifts as mice learn the cue-reward contingency
The BLA is critical for learning that previously neutral cues can predict future
punishments or rewards and for assigning valence to those cues (Baxter & Murray, 2002;
Janak & Tye, 2015). The BLA receives dense cholinergic input (Woolf, 1991; Zaborszky
et al., 2012) and we speculated that, since ACh signaling is involved in both attention and
several types of learning (Picciotto et al., 2012), it could be essential for learning about
cues that predict salient events, such as reward delivery. Based on data showing that ACh
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neurons fire in response to unexpected or salient events (Hangya et al., 2015), we also
hypothesized that ACh release might vary as mice learn a cue-reward contingency.
Therefore, we utilized the cue-reward learning task described in Chapter 2, in which
food-restricted mice were trained to perform a nose poke when signaled by a cue (tone)
to receive a palatable reward (Ensure) on a 30 sec variable intertrial interval (ITI) (Figure
2.1-Figure 2.3).
We injected adeno-associated virus (AAV) carrying an improved version of the
fluorescent ACh sensor, ACh3.0, (Jing et al., 2018, 2020) construct into the BLA of mice
and implanted an optical fiber above the BLA to record ACh signaling during the cuereward learning task (Figure 3.1 A-B). During Pre-Training, when there is no
consequence for an incorrect nose poke, animals quickly learned to make a high number
of responses over the course of each session and obtained most available rewards by day
5 of Pre-Training (Figure 3.2A, blue shaded region). During Pre-Training, when there
were high numbers of both correct and incorrect nose pokes, there was a large increase in
ACh release following correct nose pokes, which were followed by reward delivery and
cue light, but not incorrect nose pokes (Figure 3.1C). We used bootstrapped confidence
intervals (bCI) to determine when transients were statistically significant (bCI did not
contain the null of 0 (Jean-Richard-dit-Bressel et al., 2020)). Correct, but not incorrect,
nose poke trials consistently showed a sustained, significant increase in fluorescence
close to the time of nose poke onset (Figure 3.1C). We also observed a significant
decrease in fluorescence for most mice around 2-4 sec after correct nose poke, which
corresponds to the time of reward retrieval. The changes in fluorescence following nose
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pokes did not appear to be due to movement artifacts, because minimal fluctuations were
seen in the reference channel (Figure 3.1D-E).

Figure 3.1. Basolateral amygdala (BLA) ACh3.0 recording. A) Diagram and example
of injection and fiber placement sites in the BLA for recording from mice expressing a
fluorescent acetylcholine sensor (ACh3.0). Left: Diagram of BLA ACh3.0 injection and
fiber tip placement. Right: Representative coronal brain slice with fiber tip and ACh3.0
expression. Blue: DAPI, Green: ACh3.0. White dashed line: BLA outline. Grey dashed
rectangle: fiber tract. Scale = 500 µm. B) Squares indicate optical fiber tips for individual
mice. 1 (red), 2 (blue), 3 (teal), 4 (purple). C) Fluorescence traces from BLA of ACh3.0expressing mouse. A significant increase in fluorescence representing BLA ACh release
consistently coincided with correct (green line) but not incorrect (grey line) nose pokes
on last day of PT (data are shown from Mouse 1). Mean Z-scored (Z%ΔF/F0) overlaid on
bootstrapped 99% confidence intervals (99% bCIs). Shaded significance bars under
traces represent time points where 99% bCIs do not contain 0 for at least 0.5 sec. Correct:
n = 24; downsampled incorrect: n = 24 of 58. D-E) Traces of signal and reference
channels (%ΔF/F0) during nose pokes, mean ± SEM.
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The Pre-Training phase of the task did not promote learning of the cue-reward
contingency, (i.e. that they should only nose poke during tone presentation) seen by the
high number of incorrect nose pokes (Figure 3.2B, blue shaded region). Mice performed
roughly 8-fold more incorrect nose pokes than correct nose pokes, suggesting that mice
were not attending to the task contingency. On day 1 of the Training phase, when
incorrect nose pokes elicit a 5 sec timeout, all animals earned fewer rewards (Figure
3.2A, pink shading) and, while still high, incorrect nose pokes dropped (Figure 3.2B,
pink shading). Animals that did not meet acquisition criterion by day 9 (defined as
consistently earning 20 or more rewards per session, Figure 3.2A, white horizontal line)
were moved to a 20 sec variable ITI to promote responding. Following the change in ITI,
mice acquired the cue-reward behavior at different rates. After acquisition, animals were
switched to Extinction training in which correct nose pokes did not result in reward
delivery, and all mice decreased nose poke responding (Figure 3.2A-B, orange shading).
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Figure 3.2. Basolateral amygdala (BLA) ACh3.0 recording: behavior. A-B)
Behavioral responding of mice expressing ACh3.0 in BLA. A) Individual mice acquired
the task at different rates as measured by rewards earned. Horizontal white line:
acquisition threshold, when a mouse began to earn 20 rewards consistently in Training.
Pre-Training (PT): blue shaded area, Training: pink shaded area, Extinction (Ext): orange
shaded area. B) Incorrect nose poking of mice 1-4.

ACh release occurred in response to different events as mice learned the task.
Combined event heatmaps of rewarded trials, aligned to tone onset, correct nose poke,
and receptacle entry, are shown for individual mice are in Figure 3.3A-D and averaged
data across all mice at key time points in the task in Figure 3.3E. bCI plots corresponding
to the combined event heatmaps for Mouse 1 and cohort averaged data are shown in
Figure 3.5A-B. During Pre-Training rewarded trials, the highest levels of ACh release
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occurred close to the time of correct nose pokes (NP), with a smaller peak at the time of
reward retrieval (entry into the reward receptacle, Rec). As Training began, the ACh
release during reward trials shifted dramatically toward the time of reward retrieval,
likely because the animals were learning that many nose pokes did not result in reward
delivery. Incorrect nose pokes that triggered a timeout were also followed by a modest
but non-significant increase in BLA ACh levels (Figure 3.4). As mice began to learn the
contingency (Figure 3.3, 10 rewards), the peak ACh release during rewarded trials shifted
back to the time of the correct nose poke response. As animals approached the acquisition
criterion (Figure 3.3, Acq.), ACh level significantly increased at the time of the tone,
suggesting that as animals learned the cue-reward contingency, the tone became a more
salient event. At this time point, there was still a peak at the time of reward retrieval, but
its magnitude was diminished. After task acquisition, the increase in ACh following
correct nose pokes remained but was diminished, and incorrect nose pokes did not elicit
apparent ACh release (Figure 3.4B-F, Acq.). During Extinction, ACh release to tone
onset diminished.
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Figure 3.3. BLA ACh3.0 recording: reward heatmaps. A-D) Heatmaps of BLA ACh
signaling in mice 1-4 across all training phases, aligned to tone onset (Tone), correct nose
poke (NP), and receptacle entry (Rec). Each row is the average of rewarded trials across a
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training session. White dashed horizontal line: first Training day earning 10 rewards.
Horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards
consistently in Training. Black horizontal lines: divisions between training phases. Black
vertical lines: divisions between breaks in time to allow for variable latencies in tone
onset, correct nose poke, and receptacle entry (reward retrieval). E) Heatmap of BLA
ACh signaling averaged across mice. Signal aligned as in A-D with a selection of data
from key days in the behavioral paradigm shown. From bottom to top: PT Day 1, PT Day
5, Early Training Day, First Training day earning 10 rewards (white dashed horizontal
line), Mid Training Day, Acquisition Day (white horizontal line), Last Training Day, Last
Extinction Day.
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Figure 3.4. BLA ACh3.0 recording: incorrect nose pokes. A) Incorrect nose pokes that
yield timeouts (downsampled Training Day 1, pink line, n = 24 of 66) result in a modest
increase in BLA ACh signaling but incorrect nose pokes before timeouts are introduced
(downsampled PT Day 5, blue line, n = 24 of 58) do not. Data from Mouse 1 as in Figure
3.1C, Mean Z%ΔF/F0 overlaid on bootstrapped 99% confidence intervals (99% bCIs).
Shaded significance bars under traces represent time points where 99% bCIs do not
contain 0 for at least 0.5 sec. B-E) Individual mouse heatmaps of BLA ACh signaling
across all training phases, aligned to incorrect nose poke. Each row is the average of
incorrect nose pokes that led to (or would have led to for PT) a timeout across a session.
White dashed horizontal line: first Training day earning 10 rewards. Horizontal white
line: acquisition threshold, when a mouse began to earn ~20 rewards consistently in
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Training. Black horizontal lines: divisions between training phases. F) Heatmap of BLA
ACh signaling during incorrect nose poke averaged across mice. Signal aligned as in B-E
with a selection of data from key days in the behavioral paradigm shown. From bottom to
top: PT Day 1, PT Day 5, Early Training Day, First Training day earning 10 rewards
(white dashed horizontal line), Mid Training Day, Acquisition Day (white horizontal
line), Last Training Day, Last Extinction Day.

Figure 3.5. BLA ACh3.0 recording: bCI plots. A) Mouse 1 combined event bCI plot
for subset of days used in cohort averaged heatmap Figure 3.3E (from bottom to top: PT
Day 1, PT Day 5, Early Training Day, First Training day earning 10 rewards, Mid
Training Day, Acquisition Day, Last Training Day, Last Extinction Day). Mean overlaid
on 99% bCIs for tone onset, correct nose poke, and receptacle entry. Pink and blue
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significance bars under traces denote time points where 99% bCIs are above or below 0
for at least 0.5 sec, respectively. Black horizontal lines: divisions between breaks in time
to allow for variable event latencies. Horizontal scale = 1 sec. Vertical scale = 5
Z%ΔF/F0. B) Cohort averaged (mice 1-4) combined event bCI plot, as in A. Trial level
mean overlaid on 99% bCIs for tone onset, correct nose poke, and receptacle entry. Pink
and blue significance bars under traces denote time points where 99% bCIs are above or
below 0 for at least 0.5 sec, respectively. Horizontal scale = 1 sec. Vertical scale = 5
Z%ΔF/F0. C) Incorrect nose poke cohort averaged bCI plot for subset of days used in A).
Trial level mean (downsampled to 20) overlaid on 99% bCIs for incorrect nose poke.
Pink and blue significance bars under traces denote time points where 99% bCIs are
above or below 0 for at least 0.5 sec, respectively. It is unclear how to interpret the
timepoints significantly below 0 before and after incorrect nose pokes pulled out by
bootstrapping. This may be an artefact of the small signal across incorrect trials, although
this remains to be investigated. Horizontal scale = 1 sec. Vertical scale = 5 Z%ΔF/F0.

We replicated this experiment in an independent cohort of mice and found similar
results (Figure 3.6-Figure 3.8). Mice in this replicate cohort learned in a similar fashion
(Figure 3.6B + Figure 3.7A) but met the acquisition criteria faster than initial mice
because aspects of the behavioral setup were optimized (3D printed wall extensions) to
allow the imaging apparatus to be used inside sound attenuating chambers (see Methods
section). One difference observed in this group that learned the task more rapidly, was
small magnitude, but significant, increases in BLA ACh release following tone onset late
in Pre-Training (Figure 3.6C-G + Figure 3.8A-B). As behavioral performance during the
Training phase improved, ACh release to tone onset became more pronounced, as in the
initial cohort. ACh release following tone onset diminished during extinction.
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Figure 3.6. BLA ACh3.0 recording replicate. A) Squares indicate optical fiber tips for
individual mice. 5 (orange), 6 (cyan), 7 (brown), 8 (navy). B) Behavioral responding of
mice during BLA ACh3.0 recordings. Individual mice acquired the task at different rates
as measured by rewards earned. White horizontal line: acquisition threshold, when a
mouse began to earn 20 rewards consistently in Training. C-F) Heatmaps of BLA ACh
signaling in mice 5-8 across all training phases, aligned to tone onset (Tone), correct nose
poke (NP), and receptacle entry (Rec). Each row is the average of rewarded trials across a
training session. Horizontal white line: acquisition threshold, when a mouse began to earn
20 rewards consistently in Training. Black horizontal lines: divisions between training
phases. Black vertical lines: divisions between breaks in time to allow for variable
latencies in tone onset, correct nose poke, and receptacle entry (reward retrieval). Blanks
in the heatmaps indicate time bins added for alignment. G) Heatmap of BLA ACh
signaling averaged across mice 5-8. Signal aligned as in C-F with a selection of key days
shown, from bottom to top: PT Day 1, PT Day 4, Early Training, Acquisition Day (white
horizontal line), Last Training Day, Last Extinction Day.
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Figure 3.7. BLA ACh3.0 recording replicate: incorrect nose pokes. A) Incorrect nose
poking of individual mice throughout training. B-E) Individual mouse heatmaps of BLA
ACh signaling across all training phases, aligned to incorrect nose poke. Each row is the
average of incorrect nose pokes that led to (or would have led to for PT) a timeout across
a session. Horizontal white line: acquisition threshold, when a mouse began to earn 20
rewards consistently in Training. Black horizontal lines: divisions between training
phases. F) Heatmap of BLA ACh signaling during incorrect nose poke averaged across
mice. Signal aligned as in B-E with a selection of data from key days in the behavioral
paradigm shown. From bottom to top: PT Day 1, PT Day 4, Early Training Day,
Acquisition Day (white horizontal line), Last Training Day, Last Extinction Day.
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Figure 3.8. BLA ACh3.0 recording replicate: bCI plots. A) Mouse 5 combined event
bCI plot for subset of days used in Figure 3.6G (from bottom to top: PT Day 1, PT Day 4,
Early Training, Acquisition Day, Last Training Day, Last Extinction Day). Mean overlaid
on 99% bCIs for tone onset, correct nose poke, and receptacle entry. Pink and blue
significance bars under traces denote time points where 99% bCIs are above or below 0
for at least 0.5 sec, respectively. Black horizontal lines: divisions between breaks in time
to allow for variable event latencies. Horizontal scale = 1 sec. Vertical scale = 5
Z%ΔF/F0. B) Cohort (mice 5-8) averaged combined event bCI plot, aligned as in A. Trial
level mean overlaid on 99% bCIs for tone onset, correct nose poke, and receptacle entry.
Pink and blue significance bars under traces denote time points where 99% bCIs are
above or below 0 for at least 0.5 sec, respectively. Horizontal scale = 1 sec. Vertical scale
= 5 Z%ΔF/F0. C) Cohort averaged bCI plot for subset of days used in A-B.
Downsampled trial level mean overlaid on 99% bCIs for incorrect nose poke. Pink and
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blue significance bars under traces denote time points where 99% bCIs are above or
below 0 for at least 0.5 sec, respectively. Horizontal scale = 1 sec. Vertical scale = 5
Z%ΔF/F0.

After observing this increase in BLA ACh release in response to salient events
during reward learning that evolved with learning, we were curious if there would be
similar ACh dynamics in an aversive learning task. The initial BLA ACh3.0 cohort
underwent cued fear conditioning over the course of three days. On the first day
(baseline), a novel 5 sec auditory tone was presented five times. Day 2 was the toneshock fear conditioning training, in which the 5 sec tone co-terminated with a 1 sec
footshock five times. The final day was a recall test, where the 5 sec tone was presented
alone five times. On the baseline day, there was a modest, but not significant, increase in
BLA ACh release following tone onset (Figure 3.9A-B). The BLA ACh signal following
the first tone on the fear conditioning day was similar to the baseline day and the
footshock elicited a robust increase in BLA ACh (Figure 3.9A,C). Tones 3-5 resulted in
large increases in BLA ACh following tone, in addition to following shock. Interestingly,
the magnitude of shock-induced ACh signal appeared to decrease with repeated shocks
(Figure 3.9C). On the recall test day, there was a significant BLA ACh transient
following onset of all five tones (Figure 3.9A,D).
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Figure 3.9. Fear conditioning elicits BLA ACh release. BLA ACh3.0 recordings
during fear conditioning show that tone onset results in significant BLA ACh release in
after as few as 2 tone-shock pairings. Plots show 2 sec before through 3 sec after auditory
tone. Baseline and recall days only consisted of a 5 sec tone while a 1 sec footshock coterminated with tone on fear conditioning day. Dotted line = when shock occurred or
would have occurred. Shaded significance bars under traces represent time points where
99% bCIs do not contain 0 for at least 0.5 sec. A) Day averaged plots. n = 5, tones for
each day. B-D) Individual day plots show ACh release for each of the 5 tones, averaged
across mice (n = 4). B) Baseline day. C) Fear conditioning. D) Recall.

In order to determine the source of the ACh released in the BLA during cuereward learning, we recorded calcium dynamics as a measure of cell activity of ChAT+
NBM terminal fibers in the BLA (NBM-BLA), since the NBM is a major source of
cholinergic input to the BLA (Jiang et al., 2016; Woolf, 1991; Zaborszky et al., 2012).
We injected AAV carrying a Cre-recombinase-dependent, genetically-encoded calcium
indicator (DIO-GCaMP7s) into the NBM of ChAT-IRES-Cre mice and implanted an
optical fiber above the ipsilateral BLA (Figure 3.10A-D). As with the ACh3.0 sensor,
there was a significant increase in NBM-BLA cholinergic terminal activity following
correct, but not incorrect, nose pokes (Figure 3.10E-G). The changes in fluorescence
following nose pokes did not appear to be due to movement artifacts, because minimal
fluctuations were seen in the reference channel (Figure 3.10F-G). These mice acquired
the task similarly to the ACh3.0 replicate cohort, because both were recorded inside the
sound attenuating chambers (Figure 3.11).
NBM-BLA cholinergic terminal activity evolved across phases of the reward
learning task as was seen for ACh levels in the BLA (data for each mouse shown in
Figure 3.12A-B, averaged across all mice at key time points in the task shown in Figure
3.12C). Strikingly, NBM-BLA cholinergic terminal activity most closely followed
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correct nose pokes in Pre-Training and shifted primarily to tone onset as mice learned the
contingency during Training. As in the replication cohort for the ACh sensor, small
magnitude, but significant, increases in terminal activity were observed following tone
onset late in Pre-Training (Figure 3.12C). Incorrect nose pokes that resulted in a timeout
in Training sessions were followed by a modest increase in NBM-BLA cholinergic
terminal activity before task acquisition (Figure 3.13A-D). During Extinction, activity of
NBM-BLA terminals following tone onset diminished. These findings were replicated in
an independent cohort of mice, which we combined for across-mouse statistical analyses
(Figure 3.14 - Figure 3.16).
One mouse did not acquire the task after 12 days of Training (Figure 3.17C) and
interestingly, the peak in ACh release remained at the time of correct nose poke (Figure
3.17E), never shifting back to tone onset like the other 4 mice. The ACh release
following incorrect nose poke remained throughout Training for this mouse (Figure
3.17F).
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Figure 3.10. NBM-BLA GCaMP7s recording in cholinergic terminal fibers. A)
Diagram and example of Nucleus Basalis of Meynert (NBM)-BLA terminal fiber
recordings. Left: DIO-GCaMP7s was injected in the NBM of ChAT-IRES-Cre mice.
Right: Representative coronal brain slice showing GCaMP7s expression. White dashed
lines: internal capsule and globus pallidus outlines. Scale = 500 µm. B) Left: An optical
fiber was implanted above the ipsilateral BLA, Right: Representative coronal brain slice
showing GCaMP7 expression and fiber tip placement. White dashed line: BLA outline.
Grey dashed rectangle: fiber tract. Scale = 500 µm. C) Circles indicate NBM DIOGCaMP7s injection sites for individual mice, 1 (red), 2 (blue). D) Triangles indicate
estimated optical fiber tips based on adjacent slices for individual mice. 1 (red), 2 (blue).
E) NBM-BLA terminal fiber activity is similar to ACh3.0 recordings. NBM-BLA
terminal fiber activity significantly increased with correct (green line) but not incorrect
(grey line) nose pokes on last day of PT (data shown for Mouse 1). Mean Z%ΔF/F0
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overlaid on bootstrapped 99% confidence intervals (99% bCIs). Shaded significance bars
under traces represent time points where 99% bCIs do not contain 0 for at least 0.5 sec.
Correct: n = 42; downsampled incorrect: n = 42 of 101. F-G) Traces of signal and
reference channels (%ΔF/F0) during nose pokes, mean ± SEM.

Figure 3.11. NBM-BLA GCaMP7s recording in cholinergic terminal fibers:
behavior. A-B) Behavioral responding of mice during NBM-BLA terminal fiber
recordings. A) Individual mice acquired the task at different rates as measured by rewards
earned. White horizontal line: acquisition threshold, when a mouse began to earn 20
rewards consistently in Training. B) Incorrect nose poking of individual mice.
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Figure 3.12. NBM-BLA GCaMP7s recording in cholinergic terminal fibers: reward
heatmaps. A-B) Heatmaps of NBM-BLA terminal fiber activity in mice 1-2 across all
training phases, aligned to tone onset (Tone), correct nose poke (NP), and receptacle
entry (Rec). Each row is the average of rewarded trials across a training session.
Horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards
consistently in Training. Black horizontal lines: divisions between training phases. Black
vertical lines: divisions between breaks in time to allow for variable latencies in tone
onset, correct nose poke, and receptacle entry (reward retrieval). Blanks in the heatmaps
indicate time bins added for alignment. C) Heatmap of NBM-BLA terminal fiber activity
averaged across mice 1-2. Signal aligned as in A-B with a selection of key days shown,
from bottom to top: PT Day 1, PT Day 4, Early Training, Acquisition Day (white
horizontal line), Last Training Day, Last Extinction Day.
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Figure 3.13. NBM-BLA GCaMP7s recording in cholinergic terminal fibers:
incorrect nose pokes. A) Incorrect nose pokes that yield timeouts (downsampled
Training Day 1, pink line, n = 42 of 105) result in a significant increase in NBM-BLA
terminal fiber activity, but incorrect nose pokes before timeouts are introduced
(downsampled PT Day 4, blue line, n = 42 of 101) do not. Data from Mouse 1 as in
Figure 3.10E, mean Z%ΔF/F0 overlaid on bootstrapped 99% confidence intervals (99%
bCIs). Shaded significance bars under traces represent time points where 99% bCIs do
not contain 0 for at least 0.5 sec. B-C) Individual mouse heatmaps of NBM-BLA
terminal fiber activity across all training phases, aligned to incorrect nose poke. Each row
is the average of incorrect nose pokes that led to (or would have led to for PT) a timeout
across a session. Horizontal white line: acquisition threshold, when a mouse began to
earn 20 rewards consistently in Training. Black horizontal lines: divisions between
training phases. D) Heatmap of NBM-BLA terminal fiber activity during incorrect nose
poke averaged across mice 1-2. Signal aligned as in B-C with a selection of data from
key days in the behavioral paradigm shown. From bottom to top: PT Day 1, PT Day 4,
Early Training Day, Acquisition Day (white horizontal line), Last Training Day, Last
Extinction Day.
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Figure 3.14. NBM-BLA GCaMP7s recording in cholinergic terminal fibers
replicate. A) Circles indicate NBM DIO-GCaMP7s injection sites for individual mice, 3
(teal), 4 (purple). Squares indicate optical fiber tips for individual mice, 3 (teal), 4
(purple). B) Behavioral responding of mice during NBM-BLA recordings. Individual
mice acquired the task at different rates as measured by rewards earned. White horizontal
line: acquisition threshold, when a mouse began to earn 20 rewards consistently in
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Training. C-D) Heatmaps of NBM-BLA terminal fiber activity in mice 3-4 across all
training phases, aligned to tone onset (Tone), correct nose poke (NP), and receptacle
entry (Rec). Each row is the average of rewarded trials across a training session.
Horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards
consistently in Training. Black horizontal lines: divisions between training phases. Black
vertical lines: divisions between breaks in time to allow for variable latencies in tone
onset, correct nose poke, and receptacle entry (reward retrieval). Blanks in the heatmaps
indicate time bins added for alignment. E) Heatmap of NBM-BLA terminal fiber activity
averaged across mice 3-4. Signal aligned as in C-D with a selection of key days shown,
from bottom to top: PT Day 1, PT Day 4, Early Training, Acquisition Day (white
horizontal line), Last Training Day, Last Extinction Day.

Figure 3.15. NBM-BLA GCaMP7s recording in cholinergic terminal fibers
replicate: incorrect nose pokes. A) Incorrect nose poking of individual mice throughout
training. B-C) Individual mouse heatmaps of NBM-BLA terminal fiber activity across all
training phases, aligned to incorrect nose poke. Each row is the average of incorrect nose
pokes that led to (or would have led to for PT) a timeout across a session. Horizontal
white line: acquisition threshold, when a mouse began to earn 20 rewards consistently in
Training. Black horizontal lines: divisions between training phases. D) Heatmap of
NBM-BLA terminal fiber activity during incorrect nose poke averaged across mice 3-4.
Signal aligned as in B-C with a selection of data from key days in the behavioral
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paradigm shown. From bottom to top: PT Day 1, PT Day 4, Early Training Day,
Acquisition Day (white horizontal line), Last Training Day, Last Extinction Day.

Figure 3.16. NBM-BLA GCaMP7s recording in cholinergic terminal fibers: bCI
plots. A-B) Combined event bCI plots for mice 1 and 3 for with a selection of key days
shown, from bottom to top: PT Day 1, PT Day 4, Early Training, Acquisition Day, Last
Training Day, Last Extinction Day. Mean overlaid on 99% bCIs for tone onset, correct
nose poke, and receptacle entry. Pink and blue significance bars under traces denote time
points where 99% bCIs are above or below 0 for at least 0.5 sec, respectively. Horizontal
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scale = 1 sec. Vertical scale = 5 Z%ΔF/F0. C) Cohort (mice 1-4) averaged combined
event bCI plot, aligned as in A-B). Trial level mean overlaid on 99% bCIs for tone onset,
correct nose poke, and receptacle entry. Pink and blue significance bars under traces
denote time points where 99% bCIs are above or below 0 for at least 0.5 sec,
respectively. Horizontal scale = 1 sec. Vertical scale = 5 Z%ΔF/F0. D) Cohort (mice 1-4)
averaged bCI plot for subset of days used in A-C. Trial level mean (downsampled to 20)
overlaid on 99% bCIs for incorrect nose poke. Pink and blue significance bars under
traces denote time points where 99% bCIs are above or below 0 for at least 0.5 sec,
respectively. As for other experiments measuring signal before and after incorrect
nosepokes, it is unclear how to interpret the timepoints significantly below 0 pulled out
by bootstrapping. As mentioned previously, this may be an artefact of the small signal
across incorrect trials, although this remains to be investigated. Horizontal scale = 1 sec.
Vertical scale = 5 Z%ΔF/F0.
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Figure 3.17. NBM-BLA GCaMP7s recording in cholinergic terminal fibers: no shift
without acquisition. A) Orange circle indicates NBM DIO-GCaMP7s injection site for
Mouse 5. B) Orange square indicates optical fiber tip for Mouse 5. C-D) Rewards earned
and incorrect nose pokes by Mouse 5 during NBM-BLA recordings. Mouse 5 never
acquired the task. White horizontal line: acquisition threshold, when a mouse began to
earn 20 rewards consistently in Training. E) Heatmaps of NBM-BLA terminal fiber
activity in Mouse 5 across all training phases, aligned to tone onset (Tone), correct nose
poke (NP), and receptacle entry (Rec). Each row is the average of rewarded trials across a
training session. Black horizontal lines: divisions between training phases. Black vertical
lines: divisions between breaks in time to allow for variable latencies in tone onset,
correct nose poke, and receptacle entry (reward retrieval). F) Individual mouse heatmaps
of NBM-BLA terminal fiber activity across all training phases, aligned to incorrect nose
poke. Each row is the average of incorrect nose pokes that led to (or would have led to
for PT) a timeout across a session.
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In order to record NBM-BLA cholinergic terminal activity and BLA ACh levels
simultaneously in the same mouse, we injected AAV carrying a construct for Crerecombinase dependent red-shifted genetically-encoded calcium indicator (DIOjRCaMP1b) into the NBM of ChAT-IRES-Cre mice, ACh3.0 sensor into the ipsilateral
BLA, and implanted a fiber above the BLA (Figure 3.18A-E). DIO-jRCaMP1b was also
injected into the NBM of a wild type littermate so Cre-mediated recombination would not
occur to control for any crosstalk between the ACh3.0 and jRCaMP1b channels. While
this was only a single animal and proof of principle for future studies, we found that
NBM-BLA cholinergic terminal activity coincided with ACh levels (Figure 3.18F-G).
Importantly, this relationship between ACh release and NBM-BLA terminal fiber activity
was not explained by signal crosstalk (Figure 3.18H-I), further indicating that the BLA
ACh measured comes at least in part from the NBM.
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Figure 3.18. Simultaneous BLA ACh3.0 + GCaMP7s recording in NBM-BLA
cholinergic terminal fibers. A) Left: DIO-jRCaMP1b was injected in the NBM of
ChAT-IRES-Cre mice. Right: Circle indicates NBM DIO-jRCaMP1b injection site for
mouse 1. B) Left: Representative coronal brain slice showing jRCaMP1b expression.
Yellow dashed lines: internal capsule and globus pallidus outlines. Scale = 500 µm.
White box: zoomed in area shown on right. Right: Scale = 100 µm. C) ACh3.0 was
injected into the ipsilateral BLA and an optical fiber was implanted above the BLA. D)
Squares indicate optical fiber tips for individual mice. ACh3.0 + RCaMP (red), ACh3.0 +
RCaMP sham (grey). E) Coronal brain slice from ACh3.0 + RCaMP mouse. White
dashed line: BLA outline. Scale = 500 µm. F-I) Mean Z%ΔF/F0 for nose pokes on last
day of PT overlaid on bootstrapped 99% confidence intervals (99% bCIs). Shaded
significance bars under traces represent time points where 99% bCIs do not contain 0 for
at least 0.5 sec. F) A substantial increase in both fluorescence representing BLA ACh
release (green line) and NBM-BLA cholinergic terminal activity (magenta line) coincided
with correct nose pokes. n = 42. G) Modest increase in fluorescence in both channels
following incorrect nose pokes. Downsampled n = 42 of 94. H) jRCaMP1b signal is not
simply crosstalk from ACh3.0 channel. A substantial increase in fluorescence
representing BLA ACh release (green line) following correct nose pokes did not
necessitate signal in RCaMP sham red channel (grey line). n = 44. I) Incorrect nose pokes
for ACh3.0 + RCaMP sham mouse. Downsampled n = 44 of 135.

BLA principal neurons respond to reward availability and follow cue-reward learning
Glutamatergic principal cells are the primary output neurons of the BLA (Janak &
Tye, 2015), and their firing is modulated by NBM-BLA cholinergic signaling (Jiang et
al., 2016; Unal et al., 2015). BLA principal neurons can increase their firing in response
to cues as animals learn cue-reward contingencies (Sanghera et al., 1979; Schoenbaum et
al., 1998; Tye & Janak, 2007). Calcium/calmodulin-dependent protein kinase (CaMKII)
has been shown to be a marker for glutamatergic BLA principal cells (Butler et al., 2011;
Felix-Ortiz & Tye, 2014; McDonald, 1992; Tye et al., 2011). To determine whether ACh
modulates principal neuron activity during cue-reward learning, we injected AAV
carrying a Cre-recombinase dependent genetically encoded calcium indicator (DIOGCaMP6s) into the BLA of CaMKIIα-Cre mice to record BLA principal cell activity
during the learning task (Figure 3.19A-B). As was seen for BLA ACh levels, there was a
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significant increase in BLA CaMKIIα cell activity following correct nose pokes as well
as a modest decrease in activity following incorrect nose pokes on the last day of PreTraining (Figure 3.19C). The changes in fluorescence following nose pokes did not
appear to be due to movement artifacts, but there were fluctuations seen in the reference
channel (Figure 3.19D-E), likely because we were not recording at the isosbestic point
for GCaMP (see Methods,(Barnett et al., 2017; C. K. Kim et al., 2016; Sych et al., 2019).
The activity peaked later after the correct nose poke response (~2.5 sec) compared to the
ACh3.0 signal (~0.5 sec) and appeared to align more tightly with reward retrieval (Figure
3.19F). As mice learned the task (Figure 3.20A), BLA CaMKIIα cell activity increased
first in response to reward and, after acquisition of the task, to the reward-predictive cue
(Figure 3.21).
During Pre-Training, the highest levels of BLA CaMKIIα cell activity followed
reward retrieval. In addition, during the first few days of Training, BLA CaMKIIα cell
activity after reward retrieval was higher than it was during Pre-Training, and the
magnitude of response decreased as mice learned the contingency and earned more
rewards, ultimately reaching similar intensity to that observed during Pre-Training.
Concurrently, as mice approached acquisition of the task (Figure 3.20A, white horizontal
line), BLA CaMKIIα cell activity significantly increased in response to tone onset
(Figure 3.21 + Figure 3.23A-B, Acq.), suggesting that the recruitment of BLA CaMKIIα
cell activity likely reflects the association of the cue with a salient outcome (Lutas et al.,
2019; Sengupta et al., 2018). Incorrect nose pokes that triggered a timeout did not elicit a
different response in CaMKIIα cell activity compared to before timeouts were
incorporated (Figure 3.22 + Figure 3.23C).
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Figure 3.19. GCaMP6s recording in BLA CaMKIIα cells. A) Diagram and example of
injection and fiber placement sites in the BLA for recording from CaMKIIα-Cre mice
expressing a fluorescent calcium indicator (DIO-GCaMP6s). Left: Diagram of injection
and fiber placement. Right: Representative coronal brain slice with fiber tip and
GCaMP6s expression. White dashed line: BLA outline. Grey dashed rectangle: fiber
tract. Blue: DAPI, Green: GCaMP6s. Scale 500 µm. B) Squares indicate optical fiber tips
for individual mice. 1 (red), 2 (blue), 3 (teal). C) Fluorescence traces from BLA of
GCaMP6s-expressing CaMKIIα-Cre mice. During the last day PT, (data shown for
Mouse 1) correct nose pokes (green line) were followed by a modest, but significant rise
in BLA CaMKIIα cell activity that increased steeply following correct nose poke while
incorrect nose pokes (grey line) were followed by a modest decrease in activity. Mean
Z%ΔF/F0 overlaid on bootstrapped 99% confidence intervals (99% bCIs). Shaded
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significance bars under traces represent time points where 99% bCIs do not contain 0 for
at least 0.5 sec. Correct: n = 44; downsampled incorrect: n = 44 of 141. D-E) Traces of
signal and reference channels (%ΔF/F0) during nose pokes. F) The increase in BLA
CaMKIIα cell activity more closely aligned to receptacle entry (reward retrieval) on
rewarded trials, n = 44.

Figure 3.20. GCaMP6s recording in BLA CaMKIIα cells: behavior. A-B) Behavioral
responding of CaMKIIα-Cre mice expressing GCaMP6s in BLA. A) Individual mice
acquired the task at different rates as measured by rewards earned. Horizontal white line:
acquisition threshold, when a mouse began to earn 20 rewards consistently in Training.
B) Incorrect nose pokes of individual mice throughout training.
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Figure 3.21. GCaMP6s recording in BLA CaMKIIα cells: reward heatmaps. A-C)
Heatmaps of BLA CaMKIIα cell activity in mice 1-3 across all training phases, aligned to
tone onset (Tone), correct nose poke (NP), and receptacle entry (Rec). Each row is the
average of rewarded trials across a training session. White horizontal line: Day
acquisition threshold met, as determined by rewards earned. Black horizontal lines:
divisions between training phases. Black vertical lines: divisions between breaks in time
to allow for variable latencies in tone onset, correct nose poke, and receptacle entry.
Blanks in the heatmaps indicate time bins added for alignment. D) Heatmap of BLA
CaMKIIα cell activity averaged across mice 1-3. Signal aligned as in A-C with a
selection of key days shown, from bottom to top: PT Day 1, PT Day 4, Early Training
Day, Acquisition Day (white horizontal line), Last Extinction Day.
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Figure 3.22. GCaMP6s recording in BLA CaMKIIα cells: incorrect nose pokes. A)
Both incorrect nose pokes that yield timeouts (downsampled Training Day 1, pink line, n
= 44 of 124) and incorrect nose pokes before timeouts are introduced (downsampled PT
Day 4, blue line, n = 44 of 141) result in a modest decrease in BLA CaMKIIα neuron
activity. Data from Mouse 1 as in Figure 3.19C, mean Z%ΔF/F0 overlaid on
bootstrapped 99% confidence intervals (99% bCIs). Shaded significance bars under
traces represent time points where 99% bCIs do not contain 0 for at least 0.5 sec. B-D)
Individual mouse heatmaps of BLA CaMKIIα neuron activity across all training phases,
aligned to incorrect nose poke. Each row is the average of incorrect nose pokes that led to
(or would have led to for PT) a timeout across a session. Horizontal white line:
acquisition threshold, when a mouse began to earn ~20 rewards consistently in Training.
Black horizontal lines: divisions between training phases. E) Heatmap of BLA CaMKIIα
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neuron activity during incorrect nose poke averaged across mice 1-3. Signal aligned as in
B-D with a selection of data from key days in the behavioral paradigm shown. From
bottom to top: PT Day 1, PT Day 4, Early Training Day, Acquisition Day (white
horizontal line), Last Extinction Day.

Figure 3.23. GCaMP6s recording in BLA CaMKIIα cells: bCI plots. A) Mouse 1
combined event bCI plot for selection of key days, from bottom to top: PT Day 1, PT
Day 4, Early Training Day, Acquisition Day, Last Extinction Day. Mean overlaid on 99%
bCIs for tone onset, correct nose poke, and receptacle entry. Pink and blue significance
bars under traces denote time points where 99% bCIs are above or below 0 for at least 0.5
sec, respectively. Horizontal scale = 1 sec. Vertical scale = 1 Z%ΔF/F0. B) Cohort (mice
1-3) averaged combined event bCI plot, aligned as in A. Trial level mean overlaid on
99% bCIs for tone onset, correct nose poke, and receptacle entry. Pink and blue
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significance bars under traces denote time points where 99% bCIs are above or below 0
for at least 0.5 sec, respectively. Horizontal scale = 1 sec. Vertical scale = 1 Z%ΔF/F0.
C) Cohort (mice 1-3) averaged bCI plot for subset of days used in A-B. Trial level mean
(downsampled to 20) overlaid on 99% bCIs for incorrect nose poke. Pink and blue
significance bars under traces denote time points where 99% bCIs are above or below 0
for at least 0.5 sec, respectively. It is unclear how to interpret the substantial number of
timepoints significantly below 0 before and after incorrect nose pokes and may be an
artifact. Horizontal scale = 1 sec. Vertical scale = 1 Z%ΔF/F0.

In an independent cohort of mice, those with more posterior fiber tip placements
(mice 4 + 7) replicated the primary findings (Figure 3.24 - Figure 3.25).
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Figure 3.24. GCaMP6s recording in BLA CaMKIIα replicate. A) Squares indicate
optical fiber tips for individual mice. 4 (purple), 5 (orange), 6 (cyan), 7 (brown). B)
Behavioral responding of mice during BLA CaMKIIα GCaMP6s recordings. Individual
mice acquired the task at different rates as measured by rewards earned. White horizontal
line: acquisition threshold, when a mouse began to earn 20 rewards consistently in
Training. C-F) Heatmaps of BLA CaMKIIα cell activity in mice 4-7 across all training
phases, aligned to tone onset (Tone), correct nose poke (NP), and receptacle entry (Rec).
Each row is the average of rewarded trials across a training session. Horizontal white
line: acquisition threshold, when a mouse began to earn 20 rewards consistently in
Training. Black horizontal lines: divisions between training phases. Black vertical lines:
divisions between breaks in time to allow for variable latencies in tone onset, correct nose
poke, and receptacle entry (reward retrieval). Blanks in the heatmaps indicate time bins
added for alignment. G) Mouse 4 combined event bCI plot for subset of days, from
bottom to top: PT Day 1, PT Day 4, Early Training Day, Acquisition Day, Last Training
Day, Last Extinction Day. Mean overlaid on 99% bCIs for tone onset, correct nose poke,
and receptacle entry. Pink and blue significance bars under traces denote time points
where 99% bCIs are above or below 0 for at least 0.5 sec, respectively. Horizontal scale =
1 sec. Vertical scale = 5 Z%ΔF/F0.
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Figure 3.25. GCaMP6s recording in BLA CaMKIIα replicate: incorrect nose pokes.
A) Incorrect nose poking of individual mice throughout training. B-E) Individual mouse
heatmaps of BLA CaMKIIα cell activity across all training phases, aligned to incorrect
nose poke. Each row is the average of incorrect nose pokes that led to (or would have led
to for PT) a timeout across a session. Horizontal white line: acquisition threshold, when a
mouse began to earn 20 rewards consistently in Training. Black horizontal lines:
divisions between training phases.
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Discussion
It is increasingly recognized that the BLA is involved in learning to predict both
positive and negative outcomes from previously neutral cues (Cador et al., 1989; Janak &
Tye, 2015; LeDoux et al., 1990). Cholinergic cells in the basal forebrain complex fire in
response to both positive and negative reinforcement (Hangya et al., 2015). The results
shown here indicate that ACh signaling in the BLA is highly correlated with cue-reward
learning. Endogenous ACh is released in the BLA in response to salient events in the task
and ACh dynamics evolved as the subject formed associations between stimuli and
reward.
We have shown that ACh release in the BLA is coincident with the stimuli that
are the most salient to the animal at each phase of the task. Use of the fluorescent ACh
sensor was essential in determining these dynamics (Jing et al., 2018, 2020). Previous
microdialysis studies have shown that cholinergic neurons are excited in response to
positive, negative, or surprising stimuli, but this technique is limited by relatively long
timescales (several minutes) and cannot be used to determine when cholinergic transients
align to given events in an appetitive learning task and how they evolve over time (Sarter
& Lustig, 2020). In this cue-reward learning paradigm (described in Chapter 2), when
there was no consequence for incorrect nose-poking (Pre-Training phase), animals
learned to perform a very high number of nose pokes and received a large number of
rewards, and BLA ACh signaling peaked following correct nose pokes. Both the
behavioral response (nose poking that was not contingent with the tone) and the ACh
response (linked to the correct nose poke) suggest that the animals were not attending to
the tone during most of the Pre-Training phase of the task, but rather were attending to
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the cues associated with reward delivery, such as the reward light or the sound of the
pump that delivered the reward. Consistent with this possibility, in the next phase of the
task when mice received a timeout for responding if the tone was not presented,
performance of all groups dropped dramatically. Interestingly, in animals that had
difficulty learning the cue-reward contingency (such as those in Figure 3.2, that took
more than the standard 12 days to acquire during Training), ACh release shifted to
reward retrieval in early Training sessions. This shift from correct nose poke to reward
retrieval likely occurred because reward retrieval was by far the most salient aspect of the
task when the majority of nose pokes performed did not result in reward. It is not clear
why this was not observed in mice that learned at a more typical rate (such as Figure 3.6)
but future trial level analyses may reveal similarities. Finally, as mice acquired the
contingency between tone and reward availability, the tone also began to elicit ACh
release in the BLA, suggesting that mice learned that the tone is a salient event predicting
reward availability.
Since there are multiple sources of ACh input to the BLA, it was important to
determine whether NBM cholinergic neurons were active during the periods when ACh
levels were high (Woolf, 1991). Recordings from cholinergic NBM-BLA terminal fibers
showed similar dynamics to ACh measurements, suggesting that the NBM is a primary
source of ACh across the phases of cue-reward learning. For simplicity moving forward,
when I refer to ACh signaling, I am drawing conclusions from both ACh3.0 and NBMBLA cholinergic terminal fiber data since we saw similar results. It is certainly possible
that they are not fully interchangeable, especially because cholinergic neurons are known
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to release other neurotransmitters in addition to ACh (Ma et al., 2018; Saunders et al.,
2015), and this will be explored further in Chapter 5.
One of the most striking results that deserves further exploration is the shift in
which of the events elicits ACh signaling across phases of learning. Early on in Training,
the correct nose poke initiates ACh release but as the animals begin to earn more rewards
and acquire the task contingency, the ACh release following correct nose poke
diminishes and instead peaks quickly after tone onset. However, for the mouse that never
acquired the task (i.e. never passed the acquisition threshold of 20 rewards) this shift was
not observed and the peak in ACh release remained at the correct nose pokes. It is
important to note that the acquisition threshold of 20 rewards was determined based on
initial piloting that indicated that after receiving 20 rewards in a session, mice usually
continued to earn more rewards, make fewer incorrect nose pokes, and thus appeared to
be learning that they should only nose poke following tone onset; however, 20 rewards
should not be viewed as the cut off between novice and expert level behavior. For many
mice, the transition from peak ACh release following correct nose poke to peak release
following tone onset begins prior to crossing this acquisition threshold. Moreover, for
some of the faster learners, there were significant increases in ACh signaling following
tone onset late in Pre-Training, when mice are still making a large number of incorrect
nose pokes. This suggests that the association between the auditory cue and reward could
be forming before it is reflected in behavior.
While plasticity as a result of ACh signaling has been widely studied and reported
(Ballinger et al., 2016; Picciotto et al., 2012), plasticity in BF cholinergic cell activity
during learning has been examined far less. This could be due in part to the challenges in
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identifying cholinergic cells in vivo or to the possibility that ACh signaling has often been
recorded only after animals are trained to criterion. Early studies classified recorded
neurons as cholinergic or non-cholinergic based on comparison to firing property
characterizations from in vitro studies and differences in firing patterns across waking
and sleeping (Lin & Nicolelis, 2008). It is very possible this method of classification
could lead to mistakes in identification. More recently, electrophysiological recordings
have been paired with optogenetic stimulation of genetically tagged neurons to determine
the identity of recorded neurons with more precision (Hangya et al., 2015). Other studies
that employed electrochemistry to measure ACh signaling only performed recordings
after animals reached criterion instead of throughout the learning process (Howe et al.,
2013, 2017; Parikh et al., 2007), which would prevent the observation of a shift in
response related to learning. Even in one study that recorded from optogeneticallyidentified BF cholinergic neurons, only responses to primary reinforcers were reported
(Hangya et al., 2015).
However, a recent study that recorded from optogenetically-identified BF neurons
that project to auditory cortex during trace fear conditioning showed learning-related
plasticity of ACh signaling (Guo et al., 2019). This study used electrophysiological and
GCaMP6 recordings and found that when a CS and US are separated by a delay,
cholinergic BF neurons increase their activity following tone onset and, after several days
of conditioning, firing will eventually span the delay interval. Although the paradigm
used in the Guo et al. study was different from the behavior reported here (it involved a
delay between CS and US, negative valence learning), and BF cells that project to a
different region of the brain were recorded, the results of this study bear a striking
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resemblance to the plasticity seen in our cue-reward learning task. Finally, a recent
preprint used ACh3.0 in the BLA during a task in which odor cues were paired with both
positive and negative outcomes, and showed increased ACh release after either positiveor negative-paired CS (Sturgill et al., 2020).
Reward related cues were not unique in their ability to elicit ACh signaling in the
current study. During the Training phase of the task, incorrect nose pokes resulted in a 5
sec timeout that was signaled by illumination of the house light, when previously there
was no consequence. Following this change in contingency, we observed increases in
ACh signaling at the time of nosepoke that diminished as mice acquired the task—but
remained high for the mouse that never reached the acquisition threshold. It is possible
that mice were confused by the sudden introduction of the new light and mistook it for
the receptacle light that coincides with reward delivery; however, that does not seem very
likely given the timeout light is on the opposite side of the chamber and is much brighter
than the receptacle light. Instead, I believe the ACh transient following incorrect nose
suggests that BLA ACh release is unsigned, meaning it plays a role in both positive and
negative valence learning. This is in agreement with the preprint mentioned earlier
(Sturgill et al., 2020), as well as our own fear conditioning experiments in the initial BLA
ACh3.0 mice, in which we paired an auditory tone (CS) with a foot shock (US). We saw
remarkably similar plasticity during this aversive learning as in our cue-reward task,
albeit with a much faster shift in ACh response from the US to the CS. In response to a
neutral tone, the CS elicited a modest (barely above baseline) increase in ACh release,
but after just one CS+US pairing, ACh signaling increased following tone onset, and
became even more pronounced after the second pairing. At the same time, there was a
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decrease in the magnitude of ACh signaling following the shock. The amplitude of the
ACh transient after the fifth shock was only ~60% of the peak following the first shock.
Five tone-shock pairings were sufficient to elicit BLA ACh release following tone onset
alone on the recall day.
On the topic of plasticity, I believe it is worth discussing when ACh signaling
decreased in addition to when it increased. As was just mentioned for the fear
conditioning experiment, across the five tone-shock pairings, the shock-induced ACh
transient decreased as the ACh release following tone onset increased. For the cue-reward
learning task, as mice performed better during Training, the magnitude of ACh signaling
following correct nose poke decreased as the tone-evoked ACh signaling increased. The
ACh signaling following incorrect nosepokes resulting in a timeout also diminished as
mice learned the task. Notably, these decreases did not occur for the NBM-BLA mouse
that never acquired the task, suggesting this was learning related and not just novelty
based. At least for the first two instances mentioned, this decreasing ACh signaling might
be related to the predictive ability of the conditioned stimuli.
Perhaps the most well-known example of dynamic responding related to learning
cue-reward contingencies and encoding of reward prediction errors is the firing of
dopaminergic neurons of the ventral tegmental area (VTA; Schultz, 1998; Schultz et al.,
1997). After a sufficient number of pairings, dopaminergic neurons will fire in response
to the cue that predicts the reward, and no longer to the rewarding outcome, and this
corresponds with behavioral changes that indicate an association has been formed
between CS and US. What’s more, if the amount of reward actually received is more or
less than expected, dopaminergic cell firing at time of receipt increases or decreases from
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baseline, respectively, indicating that it is related to the error from the predicted reward
(Schultz, 2016). It should be noted that dopamine signaling is not unique in this learningrelated dynamic response profile. Serotonergic neuronal responses also evolve during
reward learning, but in a ramp-up manner that is distinct from dopaminergic neurons,
which suggests that different neurotransmitter systems encode different aspects of reward
and that reward-related signals can evolve differentially across phases of learning (Zhong
et al., 2017). ACh signaling does not reflect a classical reward prediction error, because
we see similar ACh release dynamics following fear conditioning (Schultz, 2016).
However, this indiscriminate coding of both positive and negative valence learning does
raise the interesting possibility of ACh signaling an unsigned prediction error (den Ouden
et al., 2012).
It is clear that ACh release is unsigned and related to the predictive quality of
conditioned stimuli but unfortunately, our current cue-reward learning task is not well
positioned to test the extent of the “error” term. We would need to modify experimental
parameters to deliver different volumes of reward across trials to see if the magnitude of
release at the time of reward retrieval differs. For instance, if double or half the reward
was given unexpectedly to the mouse, an increase or decrease in ACh signaling,
respectively, would be indicative of a prediction error. This modification would be simple
enough and may not impact overall task learning rate too much. Sturgill et al.
incorporated these types of parameters in their study and showed a lack of ACh transient
following reward omission, a larger magnitude ACh transient following uncued
compared to cued reward, and a reward-volume dependent increase in BLA ACh release.
However, even after hundreds of rewarded trials, there still appeared to be an increase in
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ACh signaling at the time of reward delivery, which is not expected from a canonical
prediction error. In addition, there does not appear to be a decrease in ACh release in
response to a stimulus that predicts reward (nose poke following the contingency change)
but does not result in its delivery. Thus, I am currently unable to determine if BLA ACh
signaling indeed encodes an unsigned prediction error. At the very least though, I believe
it is fair to say that BLA ACh signaling is released in response to some combination of
prediction, salience, and perhaps novelty. Others have suggested ACh may play a role in
uncertainty (Yu & Dayan, 2005) and learning rate (Gold, 2003; Hasselmo & Barkai,
1995).
Regardless of what learning signal ACh is encoding, there is remarkable plasticity
in responsiveness of BF cholinergic cells that has only recently become appreciated (Guo
et al., 2019). Which inputs to the cholinergic neurons in the BF underlie this plasticity?
As with many brain areas, the BF receives a diverse array of inputs from all over the
brain, ranging from noradrenergic axons from the locus coeruleus, histaminergic afferents
from the hypothalamus, adrenergic input from the medulla, among others (Zaborszky et
al., 2012; Záborszky et al., 2018). Electron microscopy studies have confirmed that BF
cholinergic neurons receive dopaminergic input from the midbrain (Zaborszky et al.,
2012), which is an intriguing candidate given the reward prediction error signaling of the
VTA mentioned above. Additionally, a recent tracing study was able to identify the
inputs to BF cholinergic neurons based on their ultimate cortical projection target and
found that BLA-projecting BF neurons receive the vast majority of their input from the
striatum, especially the caudate putamen and nucleus accumbens, as well as a sizeable
portion from the central amygdala (Gielow & Zaborszky, 2017). These are notable
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projections when considering inputs that might influence the evolution of BF cholinergic
cell activity across learning, given that both the nucleus accumbens and central amygdala
are critical for both aversive and appetitive behaviors (Ciocchi et al., 2010; Gielow &
Zaborszky, 2017; Janak & Tye, 2015; Klawonn & Malenka, 2018). These BLAprojecting BF cells received very few afferents directly from cortex or thalamus,
suggesting that the sensory input received is already processed to some degree. However,
there was reliable input to these BF neurons from a small, triangular area medial to the
medial geniculate body. This is worth mentioning because cells in this region have been
shown to be important for auditory plasticity (Gielow & Zaborszky, 2017).
As mentioned in the introduction, it would be difficult to anticipate all of the
circuit level effects of BLA ACh signaling given the rich diversity of AChRs on the
various cell types (Ballinger et al., 2016; Beyeler & Dabrowska, 2020; Janak & Tye,
2015; Picciotto et al., 2012). BLA ACh signaling has been shown to potentiate
glutamatergic signaling from incoming afferents (Jiang et al., 2016), strengthen
rhythmicity in the theta and gamma bands (Aitta-aho et al., 2018), excite specific groups
of interneurons, and modulate principal neuron activity differentially depending on the
activity level of the cell (Unal et al., 2015). In the future, I plan to use Cre-dependent
GCaMP in specific interneuron cell types, such as somatostatin, parvalbumin, and
vasoactive intestinal peptide-expressing neurons, simultaneously with the ACh3.0 sensor
to gain a better picture of how ACh signaling alters BLA activity at the circuit level (see
Chapter 5 for further discussion).
We recorded from the output neurons of the BLA in hopes of understanding how
BLA output overall during the reward learning task in which we characterized ACh
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signaling. We found that BLA CaMKIIα cells were most reliably activated following
reward retrieval before acquisition (both when they were receiving several rewards but no
timeouts in Pre-Training and few rewards early in Training). Similar to the recording of
ACh levels, after acquisition, the tone began to elicit an increase in BLA CaMKIIα cell
population activity. However, activity of CaMKIIα neurons differed from ACh signaling
in the BLA in important ways. ACh was released in response to the salient events in the
task that were best able to predict reward delivery or availability. In contrast, the activity
of BLA CaMKIIα neurons was not tightly time-locked to correct nose poking, and
instead followed reward retrieval until acquisition, when activity increased in response to
tone onset. The divergent dynamics of ACh release and CaMKIIα neuron activity
underscores that ACh’s role in the BLA is to modulate, rather than drive, the activity of
CaMKIIα neurons, and therefore may alter dynamics of the network through selective
engagement of different populations of GABA interneurons (Unal et al., 2015).
In this chapter I have shown that cholinergic inputs from the basal forebrain
complex to the BLA are likely a key component of the circuitry that links salient events
to previously neutral stimuli in the environment and uses those neutral cues to predict
future rewarded outcomes. In the next chapter I will present experiments in which I
altered BLA ACh signaling and measured the effect on behavior in the cue-reward task.
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4. Chapter 4: Manipulation of basal lateral amygdala cholinergic signaling
during reward learning
Portions of this chapter have been published in:
Crouse, Richard B, Kristen Kim, Hannah M Batchelor, Eric M Girardi, Rufina
Kamaletdinova, Justin Chan, Prithviraj Rajebhosale, et al. “Acetylcholine Is
Released in the Basolateral Amygdala in Response to Predictors of Reward and
Enhances the Learning of Cue-Reward Contingency.” eLife 9 (September 18,
2020): e57335.

Introduction
While the detection of ACh release across phases of the learning task are
suggestive that there is a role for this neurotransmitter in the learning process, these
studies are not sufficient to determine how ACh signaling contributes to cue-reward
learning. There are a number of approaches that can be employed to determine whether
ACh signaling is necessary or sufficient for this learning process, each of which has
advantages and shortcomings.
Electrical stimulation of fiber tracts is a classic way to investigate how
communication between two brain areas may affect behavior. However, this method is
particularly ill suited for studying cholinergic release in the BLA. While electrical
stimulation has great temporal resolution and some control over the area of stimulation,
there are multiple cell types in the BF in addition to cholinergic neurons (Zaborszky et
al., 2012), and BF neurons collateralize to innervate multiple brain regions (Ballinger et
al., 2016). Further, any other fibers of passage in the vicinity would also be stimulated
with this method. Therefore, the use of genetic targeting and a NBM localized injection
(similar to the NBM-BLA terminal fiber recordings in Chapter 3) would narrow
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manipulation to cholinergic neurons in the BF. That leaves the choice between
chemogenetic or optogenetic manipulation. Chemogenetic techniques such as Designer
Receptors Activated by Designer Drugs (DREADDs) allows for long term stimulation or
inhibition of genetically defined cell populations. However, chemogenetic stimulation
would occur across an entire session, with no selectivity for the time period during cue
presentation or nose-poking. In addition, use of DREADDs requires the administration of
clozapine-N-Oxide (CNO) which is metabolized to the psychoactive substance clozapine
(Manvich et al., 2018), which may have effects of its own on learning. Additionally,
using a DREADD-based approach, it would be difficult to isolate BLA-projecting NBM
cells. We therefore used an optogenetic strategy to stimulate NBM-BLA cholinergic
projections selectively during the presentation of the cue that signaled reward availability
following correct nose-pokes.
Similar to DREADDs, optogenetic constructs can be used in genetically-specified
neurons. This is achieved by packaging an inverted version of the channelrhodopsin
construct flanked by loxP sites into an adeno-associated virus and infusing it into the
NBM of ChAT-IRES-Cre mice. In this way, functional channelrhodopsin is only
expressed in cholinergic neurons in the NBM. In addition, the specific projections of
neurons that express channelrhodopsin can be targeted by implanting an optical fiber
above the region receiving the afferents (BLA). Another benefit of this method is the
flexibility in potential light delivery parameters (frequency, light power, pulse duration,
etc.). Optogenetic manipulations of the cholinergic system have been used successfully in
awake, behaving mice by others (Gritton et al., 2016; Jiang et al., 2016; Pinto et al.,
2013). In primary visual cortex, modulation of cholinergic release bidirectionally altered
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behavior in a visual discrimination task (Pinto et al., 2013). Similarly, optical stimulation
of cholinergic release in PFC increased cue detection (Gritton et al., 2016). In the BLA,
enhanced LTP and principal cell activity were observed following stimulation of
cholinergic terminals, as well as bidirectional modulation of fear learning following
optical stimulation or inhibition (Jiang et al., 2016).
We therefore used optical stimulation to increase ACh signaling in the BLA while
mice performed the cue-reward learning task. Since our fiber photometry recordings
demonstrated that ACh was released at different points in the task across phases of
learning, we hypothesized that animals would acquire the task faster with stimulation. We
also hypothesized that stimulation should be paired with reward to result in enhancement
of learning, so as a control we also stimulated release of ACh in an explicitly unpaired
pattern to see if the temporal dynamics of ACh release were essential for learning the
cue-reward contingency. Although we attempted to inhibit BLA ACh signaling using
optogenetic, DREADD, and mAChR knockdown approaches, we were met with
technological barriers that are explained in the discussion.
Whereas the optical stimulation approach would determine whether stimulation of
cholinergic terminal was sufficient for learning, this approach does not address whether it
is required for learning. Both nAChRs and mAChRs can contribute to LTP and learning
(Ballinger et al., 2016; Brunzell et al., 2006, 2006; McIntyre et al., 1998; Picciotto et al.,
1995), so we tested the necessity of these receptor subtypes for cue-reward learning by
injecting nicotinic and muscarinic AChR antagonists during learning. Finally, we injected
mice with nicotine, an exogenous agonist of nAChRs, across the cue-reward learning task
to determine whether we could measure its ability to enhance reward learning (Brunzell
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et al., 2006; Caggiula et al., 2009; Gould & Wehner, 1999; Picciotto et al., 1998), to
compare its effects with those seen in the optical stimulation experiments.

Materials and Methods
Animals
All procedures were approved by the Yale University Institutional Animal Care &
Use Committee (protocol: 2019-07895) in compliance with the National Institute of
Health’s Guide for the Care and Use of Laboratory Animals. Experiments were
performed in mice of both sexes, in keeping with the NIH policy of including sex as a
biological variable. Sex of mice in behavioral graphs is indicated by circles for females
and squares for males.
Female and male heterozygous mice with Cre recombinase knocked into the
choline acetyltransferase (ChAT) gene (ChAT-IRES-Cre, B6;129S6-Chattm2(cre)Lowl/J,
Jackson Laboratory, Bar Harbor, ME) were bred in house by mating ChAT-IRES-Cre
with C57BL6/J mice. C57BL6/J mice were obtained from The Jackson Laboratory and
tested at 5-7 months of age, following at least one week of acclimation. All mice were
maintained in a temperature-controlled animal facility on a 12-hour light/dark cycle
(lights on at 7:00 AM). Mice were group housed 3-5 per cage and provided with ad
libitum food and water until undergoing behavioral testing. Mice were single housed 1-3
weeks before surgery to facilitate food restriction and body weight maintenance.
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Surgical procedures
Surgical procedures were carried out as described in Chapter 3, with the following
modifications for optogenetic experiments: 0.5 µL of control vector (AAV2 EF1a-DIOEYFP) or channelrhodopsin (AAV2 EF1a-DIO-hChR2(H134R)-EYFP; University of
North Carolina Gene Therapy Center Vector Core, Chapel Hill, NC) was delivered
bilaterally into the NBM (A/P: - 0.7 mm, M/L ± 1.75 mm, D/V – 4.5 mm) of ChATIRES-Cre mice. Mono fiber-optic cannulas (1.25 mm outer diameter zirconia ferrule; 5
mm long, 200 µm core diameter/245 µm outer diameter, 0.37 NA, polyimide buffer outer
layer cannula; Doric Lenses) were inserted bilaterally above the basolateral amygdala
(BLA, A/P; -1.22 mm, M/L ± 2.75 mm, D/V -4.25 mm). Injection sites and optical fiber
placements are in Appendix.

Behavioral Testing
Behavioral testing was carried out as described in Chapter 2, with the following
modifications: Operant test chambers were housed in sound attenuating chambers for all
experiments, with a hole drilled in the top of the chambers to allow the patch cord to pass
through. Mice were excluded from analyses if a behavioral chamber malfunctioned (e.g.
syringe pump failed) or they received the improper compound.
Optical stimulation was generated by a 473 nm diode-pumped solid-state
continuous wave laser (Opto Engine LLC, Midvale, UT) controlled by a TTL adapter
(SG-231, Med Associates Inc.). The laser was connected to a fiber optic rotary joint
(Doric Lenses) via a mono fiber optic patch cord (200 µm core, 220 µm cladding, 0.53
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NA, FC connectors; Doric Lenses). The rotary joint was suspended above the sound
attenuating chamber with a connected branching fiber optic patch cord (200 µm core, 220
µm cladding, 0.53 NA, FC connector with metal ferrule; Doric Lenses) fed into the
behavioral box. Laser power was adjusted to yield 10-12 mW of power at each fiber tip.
The stimulation pattern was 25 ms pulses at 20 Hz for 2 sec modified from parameters in
(Jiang et al., 2016). Jiang et al. used a 20Hz pulse frequency, 5 ms pulses, and 10-12 mW
power at the fiber tips. In the current study we used a 2 sec stimulation duration because
it matched the time of syringe pump activation for reward delivery and co-terminated
with the pump and auditory tone. A 25 ms pulse width was used because our lasers were
not able to generate sufficient power with 5 ms pulses. Optical stimulation was only
delivered during the Pre-Training and Training phases of the operant task. Both control
(EYFP) and experimental (ChR2) groups received identical light delivery, and
stimulation was triggered by a correct nose poke and co-terminated with the auditory tone
and Ensure delivery. For the non-contingent experiment, the number of light stimulations
was yoked to the concurrently running ChR2 mouse. The timing of the non-contingent
stimulation was explicitly unpaired with correct nose pokes or tones, and was held in
queue until the mouse had not made a response in the last 2 sec, a tone was not going to
be delivered within the next 2 sec, or at least 5 sec had passed since the mouse entered
the receptacle after earning reward.
See Appendix 2 for number of mice that acquired, were excluded, and further
explanations for behavioral paradigm deviations.

Pharmacology
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Male wildtype C57BL/6J mice were injected i.p. 30 min prior to each PreTraining and Training session with a volume of 10 mL/kg with the following compounds:
1X DPBS (Thermo Fisher Scientific, Waltham, MA), 1 mg/kg mecamylamine
hydrochloride (Millipore Sigma, St. Louis, MO), 0.5 mg/kg (-) scopolamine
hydrochloride (Millipore Sigma), or 1 mg/kg mecamylamine + 0.5 mg/kg scopolamine.
Nicotine ditartrate salt was obtained through the NIDA Drug Supply Program.
Female wildtype C57BL/6J mice were injected subcutaneously 10 min prior to each PreTraining and Training session with a volume of 10 mL/kg with the following compounds:
1X DPBS (Thermo Fisher Scientific, Waltham, MA) or 0.2 mg/kg free base
concentration nicotine.

Cued Self-Stimulation
After Extinction, responding was reinstated in Training for 2 days. Then mice
underwent a modified Training paradigm where correct nose pokes yielded only laser
stimulation, without Ensure delivery.

Real Time Place Preference
An empty, clear mouse cage (29.5 cm x 19 cm x 12.5 cm) had half of its floor
covered in printer paper to provide a distinct floor texture. A video camera was placed
above the cage and was connected to a computer running EthoVision XT (version
10.1.856, Noldus, Wageningen, Netherlands) to track the position of the mouse and
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deliver optical stimulation when the mouse was on the laser-paired side (via TTL pulse to
OTPG_4 laser controller (Doric Lenses) connected to the laser; 20 Hz, 25 ms pulses).
Mice were randomly assigned and counterbalanced to receive laser stimulation only on
one side of the cage. Mice were allowed free access to either side for 15 min during a
session. Baseline was established in the absence of optical stimulation on Day 1. Mice
then received optical stimulation on Day 2 only when on the laser-paired side. Data are
presented as percent time spent on the laser-paired side.

Progressive Ratio Testing
In the progressive ratio test, mice were given 60 min to nose poke for Ensure and
2 sec of optical stimulation on a progressive ratio schedule (escalations given below).
Training Day escalation: 1, 2, 2, 2, 2, 3, 3, 3, 3, 3, 5, 5, 5, 5, 5, 8, 8, 8, 8, 8, 8, 11, 11, 11,
11, 11, 11, 15, 15, 15, 15, 15, 15, 22, 22, 22, 22, 22, 33, 33, 33, 33, 33, 44, 44, 44, 44, 44,
55, 66, 77, 88, 99, 133, 166, 199, 255, 313, 399, 499, 599, 777, 900,1222. Test Day
escalation: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, 219, 268,
328, 402, 492, 603, 777, 900, 1222.

Light/Dark Box Exploration
A rectangular box was divided evenly into a light (clear top, illuminated by an
8W tube light) and dark (black walls, black top) side with a black walled divider in the
middle with a small door. The lid and divider were modified to allow the optical fiber and
patch cord to pass through freely. Mice were placed facing the corner on the light side
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furthest from the divider and the latency to crossing to the dark side was measured. The
number of crosses and time spent on each side were measured for 6 min following the
initial cross.

Optical Stimulation Locomotor Activity
Mice were placed in a square box (47 cm x 47 cm x 21 cm) for 20 min with a
floor of filter paper that was changed between mice. During the 3rd 5 min bin of the
session, mice received optical stimulation (20 sec on/off, 20 Hz, 25 ms pulses).
Locomotor activity was recorded via overhead camera and analyzed in 5 min bins with
EthoVision.

Antagonists Locomotor Activity
Locomotor data was collected using an Accuscan Instruments (Columbus, Ohio)
behavior monitoring system and software. Mice were individually tested in empty cages,
with bedding and nesting material removed to prevent obstruction of infrared beams.
Mice were injected (i.p.) with saline, mecamylamine (1 mg/kg, Sigma), scopolamine (0.5
mg/kg, Sigma), or mecamylamine+scopolamine (1 mg/kg and 0.5 mg/kg, respectively)
30 min before locomotor testing. Locomotion was monitored for 20 min using 13
photocells placed 4 cm apart to obtain an ambulatory activity count, consisting of the
number of beam breaks recorded during a period of ambulatory activity (linear motion
rather than quick, repetitive beam breaks associated with behaviors such as scratching
and grooming).
97

Statistical Analyses of Behavior
Operant behavioral data saved by MEDPC IV was transferred to Excel using
MPC2XL. Data were organized in MATLAB and analyzed in Prism (V8.3.0, GraphPad
Software, San Diego, CA). Differences between groups and interactions across days for
Training were evaluated using Two-Way Repeated Measures ANOVAs. We computed
the required sample size for a 90% power level with an alpha of 0.05 by estimating the
control (EYFP) group mean would be 10 rewards and the mean experimental (ChR2)
group would be 20 rewards with a standard deviation of 5. We utilized a power calculator
for continuous outcomes of two independent samples, assuming a normal distribution.
The result was 6 samples per group. Each manipulation experiment started with at least 6
mice included in each group (Sealed Envelope | Power Calculator for Continuous
Outcome Superiority Trial, n.d.). In each experiment, each animal within a group served
as a biological replicate. These studies did not include technical replicates. Masking was
not applied during data acquisition but data analyses were semi-automated in MATLAB
and performed blind to condition.
The other behavioral assays were also analyzed with Prism with the following
tests. Real time place preference and optical stimulation locomotor activity: two-way
repeated-measures ANOVA. Antagonist locomotor activity: one-way ANOVA. Lightdark exploration: unpaired t-tests.

Ex Vivo Electrophysiology Slice preparation
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Coronal brain slices were prepared from virus injected mice after 3 weeks from
surgery. Animals were anesthetized with a mixture of ketamine and xylazine (100 mg
ketamine and 6 mg xylazine/kg body weight injected i.p.). Then the mice were
transcardially perfused with a sucrose-based solution (see below). After decapitation, the
brain was rapidly transferred into a sucrose-based cutting solution bubbled with 95%O2
and 5% CO2 and maintained at ~3°C. This solution contained (in mM): sucrose 230; KCl
2.5; MgSO4 10; CaCl2 0.5; NaH2PO4 1.25; NaHCO3 26; glucose 10 and pyruvate1.5.
Coronal brain slices (300µm) were prepared using a Leica VT1000S vibratome (Leica
Biosystems Inc). Slices were equilibrated with a mixture of oxygenated artificial
cerebrospinal fluid (aCSF) and sucrose-based cutting solution at room temperature (2426°C) for at least 1 hour prior to transfer to the recording chamber. Pyruvate (0.15–0.75
mM) was added to reduce oxidative damage and enhance survival. With this protocol,
slices are initially incubated in a mixture of 50% cutting solution with pyruvate and 50%
aCSF (in mM): sucrose 115; NaCl 63; KCl 2.5; NaH2PO4 1.25; MgSO4 5; CaCl21.25;
MgCl2 1; NaHCO3 26; glucose 10; and sodium pyruvate 0.75 at 35°C for 30 min and then
transferred to a mixture of 10% cutting solution and 90% aCSF (in mM): sucrose 23;
NaCl 113.4; KCl 2.5; NaH2PO4 1.25; MgSO4 1; CaCl2 1.85; MgCl2 1.8; NaHCO3 26;
glucose 10; and sodium pyruvate 0.15 at 35°C for 1–4 h prior to recording. The slices
were continuously superfused with aCSF at a rate of 2ml/min containing (in mM); NaCl
126, KCl 2.5, NaH2PO4 1.25, NaHCO3 26, CaCl2 2, MgCl2 2 and glucose 10 bubbled
with 95% O2 and 5% CO2 at room temperature.

Ex Vivo Electrophysiological recordings

99

Brain slices were placed on the stage of an upright, infrared-differential interference
contrast microscope (Olympus BX51WI, Olympus). NBM neurons were visualized with a
40 X water-immersion objective by infrared microscopy (COHU 4915 camera, COHU,
Inc., Poway, CA). Patch electrodes with a resistance of 4–6 MΩ were pulled with a laserbased micropipette puller (P-2000, Sutter Instrument Company). Signals were recorded
with a Multi Clamp 700A amplifier and pClamp10 software (Molecular Devices, Inc., San
Jose, CA). The pipette solution contained (in mM) 130 K-gluconate, 2 KCl, 2 MgCl2, 10
HEPES, 0.5 EGTA, 1 ATP and 0.2 GTP (pH=7.3).
To examine action potential firing frequency, NBM neurons were recorded in a
current clamp configuration after forming a giga-ohm seal. Membrane potentials were
clamped at -60 mV by injecting 0-~50 pA current through the recording electrode as
needed. Cells that maintained steady membrane potentials for at least 5 mins were included
in the analysis.
Optogenetic Stimulation Ex Vivo
Channelrhodopsin was activated with a train of light flashes delivered through the
40x microscope objective. The light source was an Olympus x-cite 120Q lamp (Olympus)
gated with a TTL controlled shutter (LAMBDA SC, Sutter Instrument). The filter cube
contained an HQ480/40x excitation filter, a Q505lp bypass filter and an HQ535/50m
emission filter (Chroma Technology Corp., Bellows Falls, VT). The fluorescence
illumination intensity delivered at the brain slices was adjusted to 1-3 mW/mm2, measured
with a PM100D optical power and energy meter (Thorlabs Inc., Newton, NJ). In the NBM,
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cholinergic neurons were identified by EGFP fluorescence and light flashes were delivered
at 1 Hz, 5 Hz, 10 Hz, 15Hz, 20 Hz, 25 Hz, and 30 Hz.

Results
Stimulation of cholinergic terminals in BLA improves cue-reward learning
Since ACh released by NBM-BLA terminals during Training shifted to tone onset
during acquisition of cue-reward learning (Figure 3.3 + Figure 3.12), we hypothesized
that ACh may potentiate learning the cue-reward contingency. We therefore tested
whether increasing ACh release in BLA during learning could alter cue-reward learning
by injecting AAV carrying a Cre-recombinase-dependent channelrhodopsin-EYFP
(AAV-DIO-ChR2-EYFP) construct bilaterally into the NBM of ChAT-IRES-Cre
transgenic mice and placing fibers over the BLAs to optically stimulate cholinergic
terminals originating from the NBM selectively (Figure 4.1A-D). Optical control over
ChAT+ NBM cells was verified by ex vivo slice recordings, depolarizations followed
light flashes and clear action potentials were observed ex vivo (Figure 4.1E-J).
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Figure 4.1. Strategy and ex vivo demonstration of optical stimulation of NBM-BLA
cholinergic terminal fibers. A) Bilateral AAV injection of Cre-dependent ChR2-EYFP
into the NBM of ChAT-IRES-Cre mice to gain optical control over ChAT+ NBM cells or
control fluorophore, DIO-EYFP. B) Representative coronal brain slice showing ChR2EYFP expression. White dashed lines: internal capsule and globus pallidus outlines.
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Scale: 500 µm C) Bilateral optical fiber implantation above BLA to stimulate BLAprojecting ChAT+ NBM cells. D) Representative coronal brain slice showing ChR2EFYP expression and fiber tip placement. Grey dashed rectangle: fiber tract. White
dashed: BLA outline. Scale: 500 µm. E-J) Current clamp recordings of ChAT+ NBM
cells expressing ChR2. Optical stimulation was delivered at the indicated frequency.

After operant familiarization, ChAT+ NBM-BLA terminals were stimulated via
bilateral optical fibers (2 sec, 20 Hz, 25 ms pulses) triggered by a correct nose poke
throughout both Pre-Training (Figure 4.2A) and Training (Figure 4.2B). Stimulation
usually occurred during at least a portion of all three components of a rewarded trial:
tone, correct nose poke, and reward retrieval, since these events were often separated by
short latencies.
As seen in previous experiments, during the Pre-Training phase animals made a
high number of nose poke responses over the course of each session, obtained most
available rewards by the last day (Figure 4.2C,E, blue shading), and committed a very
high number of incorrect nose pokes (Figure 4.2D,F, blue shading). There were no
differences in rewards earned (main effect of group (EYFP vs. ChR2) in a two-way
repeated-measures ANOVA, F (1, 9) = 1.733, p = 0.2205) or incorrect nose pokes (main
effect of group (EYFP vs. ChR2) in a two-way repeated-measures ANOVA, F (1, 9) =
0.002433, p = 0.9617) between the EYFP control (n = 5) and ChR2 (n = 6) groups during
the Pre-Training phase (Figure 4.2C-F, blue shading), suggesting that increasing BLA
ACh signaling was not sufficient to modify behavior during the Pre-Training phase of the
task.
On Day 1 of the Training phase, all animals earned fewer rewards (Figure 4.2C,E,
pink shading) and incorrect nose pokes remained high (Figure 4.2D,F, pink shading). As
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the animals learned that a nose poke occurring outside of the cued period resulted in a
timeout, both control EYFP and ChR2 groups learned the contingency and improved
their performance, resulting in acquisition of the cue-reward task (20 rewards earned).
However, significant group differences emerged, such that ChR2 mice earned
significantly more rewards than EYFP controls (Figure 4.2C,E, pink shaded; main effect
of group (EYFP vs. ChR2) in a two-way repeated-measures ANOVA, F (1, 9) = 9.434, p
= 0.0133), and there was a significant Day x Group (EYFP vs. ChR2) interaction (twoway repeated-measures ANOVA, F (11, 99) = 3.210, p = 0.0009). ChR2 mice also made
significantly fewer incorrect nose pokes than control mice (Figure 4.2D,F, pink shaded;
two-way repeated-measures ANOVA, F (1, 9) = 12.67, p = 0.0061), suggesting that the
ChR2 group learned the tone-reward contingency more quickly than the EYFP group.
EYFP mice were able to reach the same peak cue-reward performance as the ChR2 group
only after 4-6 additional days of training. Once peak performance was achieved, there
was no difference in extinction learning between the groups (main effect of group (EYFP
vs. ChR2) in a two-way repeated-measures ANOVA, F (1, 9) = 2.293, p = 0.1643).
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Figure 4.2. Stimulation of cholinergic NBM-BLA terminal fibers enhances cuereward learning. A-B) Details of the cue-reward learning paradigm. A) During PreTraining, auditory tones were presented on a variable interval 30 schedule (VI30), during
which an active nose poke (correct) yielded Ensure reward delivery and 2 sec of optical
stimulation but there was no consequence for incorrect nose pokes (active nose pokes not
during tone). B) Training was identical to Pre-Training, except incorrect nose pokes
resulted in a 5 sec timeout, signaled by house light illumination, followed by a restarting
of the ITI. C-D) Behavioral performance in a cue-reward learning task improves with
optical stimulation of ChAT+ fibers in BLA of female mice. C) EYFP- and ChR2expressing mice earn similar numbers of rewards during Pre-Training (PT, blue shaded
region). ChR2-expressing mice more rapidly earn significantly more rewards than EYFPexpressing mice during Training (pink shaded region). No significant differences were
observed during extinction training (orange shaded region). Horizontal white line:
acquisition threshold, when a mouse began to earn ~20 rewards consistently in Training.
Mean ± SEM, EYFP: n = 5, ChR2: n = 6. D) EYFP- and ChR2-expressing mice made
similar numbers of incorrect nose pokes during Pre-Training. ChR2-epxressing mice
made significantly fewer incorrect nose pokes than EYFP-expressing mice in Training.
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No significant differences were observed during extinction training. Mean ± SEM,
EYFP: n = 5, ChR2: n = 6. E-F) Individual mouse data for C-D. See Appendix 3 for
injection sites and fiber placements.

While sex differences in the behavior were not formally tested side by side, an
independent cohort of male mice (EYFP n = 7, ChR2 n = 7, Figure 4.3) was tested to
determine whether both male and female mice would respond to ACh stimulation,
revealing similar trends during Training for rewards earned (Figure 4.3A,C, pink shaded;
two-way repeated-measures ANOVA, Group main effect (EYFP vs. ChR2): F (1, 12) =
3.636, p = 0.0808, Day x Group interaction: F (11, 132) = 3.033, p = 0.0012) and
incorrect nose pokes (Figure 4.3B,D, pink shaded; two-way repeated-measures ANOVA,
Group main effect (EYFP vs. ChR2): F (1, 12) = 4.925, p = 0.0465).

Figure 4.3. Stimulation of cholinergic NBM-BLA terminal fibers enhances cuereward learning in male mice. A) Optical stimulation of ChAT+ NBM-BLA terminal
fibers (ChR2-expressing mice, blue squares) had a similar effect on rewards earned
during Training in male mice compared to female mice. Mean ± SEM, EYFP: n = 7,
ChR2: n = 7. Horizontal white line: acquisition threshold, when a mouse began to earn
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~20 rewards consistently in Training. B) Optical stimulation of ChAT+ NBM-BLA
terminal fibers (ChR2-expressing mice, blue squares) had a similar effect on incorrect
nose pokes during Training in male mice compared to female mice. Mean ± SEM, EYFP:
n = 7, ChR2: n = 7. C-D) Individual mouse data for A-B. See Appendix 4 for injection
sites and fiber placements.

In order to determine if optical stimulation of NBM-BLA cholinergic terminals
improved performance in the task by increasing the rewarding value of the outcome,
rather than enhancing cue-reward learning by some other means, we allowed mice to
nose poke for optical stimulation rather than for Ensure (Figure 4.4A). There were no
differences between the EYFP control and ChR2 groups (two-way repeated-measures
ANOVA, F (1, 9) = 0.6653, p = 0.4357). We also tested whether NBM-BLA cholinergic
terminal activation was reinforcing on its own by stimulating these terminals in a realtime place preference test. Mice were allowed to explore two similar compartments to
determine baseline preference, and NBM-BLA cholinergic terminals were then
stimulated in one of the two chambers to determine whether it increased time spent in the
simulation-paired chamber. There was no difference between groups (Figure 4.4B, main
effect of group (EYFP vs. ChR2) in a two-way repeated-measures ANOVA, F (1, 9) =
0.1311, p = 0.7257) in place preference, confirming that optical activation of NBM-BLA
cholinergic terminals is not innately rewarding. Stimulation of NBM-BLA cholinergic
terminals also did not lead to changes in nose poke behavior in an uncued progressive
ratio task (Figure 4.4C, main effect of group (EYFP vs. ChR2) in a two-way repeatedmeasures ANOVA, F (1, 12) = 0.0009814, p = 0.975). Locomotor behavior was also not
significantly affected by NBM-BLA cholinergic terminal activation (Figure 4.4D, twoway repeated-measures ANOVA, F (1, 9) = 0.05804, p = 0.8150.) Finally, to determine
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whether there was any effect of NBM-BLA cholinergic terminal stimulation on
preference for, or avoidance of, a stressful environment, mice were tested for changes in
time spent in the dark or light side due to laser stimulation in the Light/Dark Box test, and
there were no differences between the groups (Figure 4.4E-F, unpaired t-tests, number of
crosses: p = 0.3223; time in light side: p = 0.1565).
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Figure 4.4. Additional behavioral assays with cholinergic NBM-BLA optical
stimulation. A-B, D-F: Female mice from Figure 4.2, E: Male mice from Figure 4.3. A)
Stimulation of ChAT+ NBM-BLA terminal fibers did not support self-stimulation. Mice
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were allowed to nose poke for 2 sec of stimulation in the Training paradigm. B)
Stimulation of ChAT+ NBM-BLA terminal fibers did not support real time place
preference. Mice were allowed to move freely between two sides of an empty cage with
distinct floor contexts for 15 min. Data are reported as percent time spent on the laserpaired side. Closed circles: Mean ± SEM, open circles: data for individual mice. C)
Stimulation of ChAT+ NBM-BLA terminal fibers during a progressive ratio test did not
affect active nose poking. Closed squares: Mean ± SEM, open squares: individual mice.
D) There were no differences between EYFP- and ChR2-expressing mice in locomotor
activity. X-axis ticks = 5 min bins, Laser = 5 min of 20 sec on/off optical stimulation.
Closed circles: Mean ± SEM, open circles: data for individual mice. E-F) No difference
in behavior was seen between EYFP- and ChR2-expressing mice on any measures in the
Light/Dark Box Test.

Muscarinic, but not nicotinic, receptors are required for acquisition of the cue-reward
contingency
ACh signals through multiple receptor subtypes, with rapid, ionotropic signaling
mediated through stimulation of nAChRs, and metabotropic signaling mediated through
stimulation of mAChRs (Picciotto et al., 2012). To determine which ACh receptors were
involved in this cue-reward learning task, mice were injected intraperitoneally with saline
(n = 8), mecamylamine (non-competitive nicotinic antagonist, Mec, n = 9), scopolamine
(competitive muscarinic antagonist, Scop, n = 8), or a combination of both antagonists
(Mec+Scop, n = 9) 30 min prior to Pre-Training and Training, during the same epochs of
the task in which optical stimulation was administered (Figure 4.5). Like optical
stimulation, blockade of ACh receptors during the Pre-Training phase of the task had no
effect on rewards earned (Figure 4.6A,C, blue shading, main effect of Group (antagonist)
in a two-way repeated-measures ANOVA, F (3, 30) = 1.285, P=0.2973) or on the large
number of incorrect nose pokes (Figure 4.6B,D, blue shading, main effect of Group
(antagonist) in a two-way repeated-measures ANOVA, F (3, 30) = 1.496, p = 0.2356). In
contrast, blockade of muscarinic signaling abolished the ability of mice to learn the
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correct cue-reward contingency during the Training period (Figure 4.6A,C, pink shading,
two-way repeated-measures ANOVA, Antagonist main effect: F (3, 30) = 23.13, p <
0.0001, Day x Antagonist interaction: F (33, 330) = 10.79, p < 0.0001), with these mice
maintaining high levels of incorrect nose pokes for the duration of Training compared to
Saline and Mec treated mice (Figure 4.6B,D, pink shading, main effect of Group
(antagonist) in a two-way repeated-measures ANOVA, F (3, 30) = 25.64, p < 0.0001).
Saline and Mec groups were not significantly different in any phase of the task, including
across Extinction (Figure 4.6A-D, orange shading, main effect of Group (antagonist) in a
two-way repeated-measures ANOVA, F (1, 15) = 1.201, p = 0.2903). We have shown
that this dose of mecamylamine delivered i.p. has significant effects in tests of anxietylike behavior and responses to inescapable stress. In addition, chronic treatment with
mecamylamine at this dose is sufficient to decrease BLA c-fos immunoreactivity (Mineur
et al., 2007). Consistent with the inability to acquire the cue-reward contingency, mice
treated with Scop or Mec+Scop also obtained very few rewards during Extinction (Figure
4.6A,C, orange shading). The antagonists had no effect on locomotion as measured by
beam breaks (Figure 4.6E) one-way ANOVA, F (3, 30) = 0.5074, p = 0.6802).

Figure 4.5. ACh receptor antagonism experiment timeline. A) Timeline of drug
administration. Saline or ACh receptor (AChR) antagonists were delivered i.p., 30 min
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before PT and Training sessions, the same phases of the task as optical stimulation
experiments.

Figure 4.6. Muscarinic, but not nicotinic, ACh receptor antagonism prevents
learning of a cue-reward contingency. A-D) Behavioral performance of mice
administered AChR antagonists. A) AChR antagonists had no significant effect on
rewards earned during Pre-Training (PT, blue shaded region). Muscarinic AChR
antagonism (Scop and Mec+Scop) resulted in significantly fewer rewards earned during
Training (pink shaded region). There was no significant difference between saline
controls and those receiving the nicotinic AChR antagonist (Mec) during Training. Mice
extinguished responding at similar rates (Ext, orange shaded region). Mean ± SEM Saline
(n = 8), Mec (n = 9), Scop (n = 8), Mec+Scop (n = 9). Horizontal white line: acquisition
threshold, when a mouse began to earn ~20 rewards consistently in Training. B) Incorrect
nose poking was not affected by AChR antagonism during PT but Scop- and Mec+Scop-

112

treated mice maintained high levels of incorrect nose pokes compared to Saline- and
Mec-treated mice throughout Training. Mean ± SEM, Saline (n = 8), Mec (n = 9), Scop
(n = 8), or Mec+Scop (n = 9). C-D) Individual mouse data for A-B. E) There were no
differences in locomotion for antagonists.

ACh-mediated accelerated cue-reward learning does not require contingent
stimulation of ChAT+ NBM terminals in the BLA
Acetylcholine is often thought of as a neuromodulator (Picciotto et al., 2012), and
the window for cholinergic effects on synaptic plasticity varies across ACh receptor
subtypes (Gu & Yakel, 2011). It is therefore possible that ACh signaling may result in
intracellular signaling changes that outlast the cue presentation window. In order to
determine if the effect of NBM-BLA stimulation is dependent upon the timing of correct
nose poke and laser stimulation contingency, we repeated the experiment in an
independent cohort of mice with an additional non-contingent ChR2 group that received
the same number of stimulation trains as the contingent ChR2 group, but in which light
stimulation was explicitly unpaired with task events (Figure 4.7).
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Figure 4.7. Optical stimulation paradigm for Non-contingent-ChR2 group. A) Noncontingent-ChR2-expressing mice received the same number of light stimulations as
contingent-ChR2-expressing mice, but stimulation was only given during the ITI, when
non-contingent mice had not made a response within 2 sec.

As in the previous experiment, there were no differences between the EYFP
control (n = 6) and stimulation groups (contingent-ChR2 n = 5 and non-contingent ChR2
n = 5) during Pre-Training (Figure 4.8, blue shading; main effect of group (EYFP vs.
contingent-ChR2 vs. non-contingent ChR2) two-way repeated-measures ANOVAs;
rewards earned: F (2, 13) = 0.7008, p = 0.5140; incorrect nose pokes: F (2, 13) = 0.3906,
p = 0.6843). However, the non-contingent ChR2 group was not significantly different
from the contingent ChR2 group during the Training period with respect to number of
rewards earned (two-way repeated-measures ANOVA, F (1, 8) = 0.09147, p = 0.7700) or
incorrect nose pokes (two-way repeated-measures ANOVA, F (1, 8) = 0.3681, p =
0.5609), but both ChR2 groups were significantly better than the EYFP control group
(Figure 4.8, pink shading; two-way repeated-measures ANOVAs; rewards earned: Group
(EYFP vs. contingent-ChR2 vs. non-contingent-ChR2) main effect: F (2, 13) = 7.254, p
= 0.0077; Day x Group interaction: F (22, 143) = 1.861, p = 0.0164. Incorrect nose
pokes: Group main effect: F (2, 13) = 4.884, p = 0.0262.). These results demonstrate that
ChR2-mediated ACh release does not have to be time-locked to the cue, nose poke, or
reward retrieval to improve performance of the task, suggesting that ACh may alter the
threshold for neuronal plasticity for cue-reward pairing over a much longer timescale
than might be expected based on results from the ACh3.0 recording and NBM-BLA
recordings, which could be consistent with the involvement of mAChR signaling in this
effect. As in the previous experiment, once all groups reached criterion for acquisition of
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the cue-reward contingency, there were no differences between any of the groups during
Extinction (Figure 4.8, orange shaded; two-way repeated-measures ANOVA, F (2, 13) =
0.04229, p = 0.9587).

Figure 4.8. Non-contingent stimulation of cholinergic NBM-BLA terminals is
sufficient to enhance cue-reward learning. A) Non-contingent NBM-BLA optical
stimulation also improves behavioral performance in cue-reward learning task. There was
no significant difference in the number of rewards earned between EYFP (n = 6),
contingent-ChR2 (n = 5), or non-contingent-ChR2 (n = 5) mice during Pre-Training.
Contingent- and non-contingent-ChR2-expressing mice more rapidly earned significantly
more rewards during Training than EYFP-expressing mice. No differences were observed
between groups during extinction training. Mean ± SEM, EYFP: n = 6, contingent-ChR2:
n = 5, non-contingent-ChR2: n = 5. Horizontal white line: acquisition threshold, when a
mouse began to earn 20 rewards consistently in Training. B) Incorrect nose pokes. There
was no significant difference in the number of incorrect nose pokes between groups
during Pre-Training. Contingent- and non-contingent-ChR2-expressing mice made
significantly fewer incorrect nose pokes during Training than EYFP-expressing mice. No
differences between groups were observed during extinction training. Mean ± SEM
EYFP: n = 6, contingent-ChR2: n = 5, non-contingent: n = 5. C-D) Individual mouse data
for A-B. See Appendix 5 for injection sites and fiber placements.

Nicotine adminsitration may improve cue-reward learning
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Non-contingent nicotine administration can enhance responding for cues in an
operant task (Caggiula et al., 2009). Thus, despite the lack of effect of the nAChR
antagonist mecamylamine on cue-reward learning, it was still possible that enhancing
nicotinic signaling could alter performance in the task. We therefore administered
nicotine (dose, s.c.) to female mice 10 min before each Pre-Training and Training session
(Figure 4.9). There were no differences between number of rewards earned (main effect
of group (saline vs. nicotine) in a two-way repeated-measures ANOVA, F (1, 18) =
0.3686 , p = 0.5513) or incorrect nose pokes (main effect of group (saline vs. nicotine) in
a two-way repeated-measures ANOVA, F (1, 18) = 0.1411, p = 0.7116) during PreTraining (Figure 4.9, blue shading). The nicotine group did not earn significantly more
rewards than saline controls (main effect of group (saline vs. nicotine) in a two-way
repeated-measures ANOVA, F (1, 18) = 3.908, p = 0.0636). However, there was a
significant decrease in number of incorrect nose pokes made by nicotine-treated mice
compared to saline controls (main effect of group (saline vs. nicotine) in a two-way
repeated-measures ANOVA, F (1, 18) = 4.477, p = 0.0485).
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Figure 4.9. Subcutaneous nicotine administration induced a modest improvement in
cue-reward learning. A-D) Behavioral performance of mice administered subcutaneous
saline (n = 10) or 0.2 mg/kg nicotine (n = 10) 10 min before each Pre-Training and
Training session. A) Nicotine administration had a trending effect on the number of
rewards earned during Training (pink shaded region), but not Pre-Training (PT, blue
shaded region). Mice extinguished responding at similar rates (Ext, orange shaded
region). Mean ± SEM. Horizontal white line: acquisition threshold, when a mouse began
to earn ~20 rewards consistently in Training. B) Mice administered nicotine made
significantly fewer incorrect nose pokes. Mean ± SEM. C-D) Individual mouse data for
A-B.

Discussion
In this chapter, I show that using optogenetics to stimulate NBM-BLA cholinergic
terminals during learning enhanced behavioral performance, but was not intrinsically
rewarding on its own and did not support responding for the tone alone. The effects of
heightened BLA ACh signaling were relatively long lasting, since it was not necessary
for stimulation to be time-locked to cue presentation or reward retrieval to enhance
behavioral performance. Muscarinic, but not nicotinic, receptors were necessary for the
acquisition of this task. Interestingly though, nicotine administration led to a modest
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increase in task performance, in the same direction as the NBM-BLA cholinergic
terminal stimulation.
Neuronal activity and plasticity in the BLA is required for both acquisition of
appetitive learning (conditioned reinforcement) and fear conditioning, however the inputs
that increase activity in the structure during salient events likely come from many brain
areas (McKernan & Shinnick-Gallagher, 1997; Rogan et al., 1997; Tye et al., 2008). In
particular, dopaminergic inputs to the BLA are important for acquisition of conditioned
reinforcement and for linking the rewarding properties of addictive drugs to cues that
predict their availability (Cador et al., 1989). Our results indicate that ACh is a critical
neuromodulator released in the BLA that is responsive to salient events, such as reward
availability, motor actions that elicit reward, or cues that predict reward.
Increasing endogenous ACh signaling in the BLA caused mice to perform
significantly better than controls in this appetitive cued-learning task. Heightened ACh
release during learning of a cue-action-reward contingency led to fewer incorrect
responses and increased acquisition rate in both female and male mice. The optical
stimulation was triggered by correct nose poke, thus the cholinergic NBM-BLA terminal
fiber stimulation overlapped with all three salient events: tone, nose poke, and reward
retrieval, since the tone terminated 2 sec after correct nose poke and mice entered the
receptacle often under 2 sec. We chose this stimulation pattern, as opposed to linking
optical stimulation to tone onset, to ensure stimulation was dependent on behavioral
responses. Behaviorally-contingent increases in BLA ACh were sufficient to enhance
task acquisition (but see below).
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It is possible that optogenetic-mediated ACh release may last longer than
endogenous, tone-evoked release, but we do not have data from this set of studies to
know whether this is the case. A simultaneous stimulation and recording approach would
be required to compare ACh release under both conditions (Pisansky et al., 2019).
Additionally, based on the ex vivo current clamp recordings performed, it is possible that
the stimulation parameters used here did not elicit action potentials with every pulse and
instead depolarized axons and heightened their excitability. We chose these optical
stimulation parameters based on the work of collaborators (Jiang et al., 2016), but the
previous study used a different channelrhodopsin variant (oChIEF). Thus,
characterization of optogenetic-evoked ACh release in vivo would be useful to resolve
these outstanding questions. It is also important to note that basal forebrain neurons can
co-release ACh and GABA (Ma et al., 2018; Saunders et al., 2015), and cholinergic basal
forebrain neurons that project to the BLA have been shown to co-express a glutamate
transporter (Ma et al., 2018; Poulin et al., 2006). Thus, it is possible that these
optogenetic results could be influenced, in part, by co-release of other neurotransmitters
from ChAT-positive neurons. Future studies employing additional fluorescent
neurotransmitter sensors (Marvin et al., 2013, 2018, 2019) or additional pharmacological
blockers could help understand the interaction between the different signals employed by
basal forebrain neurons.
Increasing BLA ACh signaling enhanced learning but it is not clear what facet of
learning, or other process related to the task, was augmented. It is possible that ACh
improved learning by increasing the intensity of the reward, potentiating the learned
association, improving discrimination (Pinto et al., 2013), improving cue detection
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(Gritton et al., 2016), or a combination of these and other phenomena. However,
increasing ACh release in the BLA was not inherently rewarding, because it did not
support self-stimulation or real-time place preference. This is at odds with a recent study
that found stimulation of NBM-BLA cholinergic terminals could induce a type of placepreference and modest self-stimulation (Aitta-aho et al., 2018). Perhaps slight differences
in targeting of ChR2 infusion or differences in the behavioral paradigm could be
responsible for the lack of direct rewarding effects of optical ChAT terminal stimulation
in the current study. Other recent work (Jiang et al., 2016) has demonstrated that
stimulating this NBM-BLA cholinergic pathway is sufficient to strengthen cued aversive
memory, suggesting that the effect of ACh in the BLA may not be inherently rewarding
or punishing, but instead potentiates plasticity in the BLA, allowing learning of cueoutcome contingencies. Several studies that have measured ACh signaling in mPFC have
found that it is instrumental in cue detection (Gritton et al., 2016; Howe et al., 2013;
Parikh et al., 2007; Sarter et al., 2016). Importantly, cue detection in these studies is
defined as the entire process by which an animal perceives a stimulus through performing
a response to the cue. Not only did these studies identify short-latency ACh transients
(measured by amperometric detection of choline currents) following only detected cues,
but they also found that optogenetically stimulating BF ACh release led to higher false
alarms in an attentional paradigm. The contingent-stimulation paradigm used here would
not allow us to test this possibility, because mice receive stimulation after detecting the
cue. However, results from the non-contingent experiment could be used to test this
hypothesis to some extent. While there was no difference in overall incorrect nose pokes
in the non-contingent group, it is possible that there are trial level differences in these
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mice. For instance, if a mouse is more likely to make an incorrect nose poke after
delivery of non-contingent stimulation, we would not be able to measure this by
averaging across a session. Future analyses can be performed to follow up on this
interesting possibility.
Yet another possible explanation for the effect of ACh BLA terminal stimulation
on learning could be that the manipulation altered motor activity. However, there were no
effects of optical stimulation on locomotion or responding in the inactive nose poke port.
In addition, during the Pre-Training phase when there was no consequence for incorrect
nose pokes, all groups earned the same number of rewards, regardless of optical
stimulation or pharmacological blockade of ACh receptors, suggesting that ACh is not
involved in the motor aspects of the task or the value of the reward. Indeed, differences
emerged only during the Training phase, when attention to the tone was critical to earn
rewards. Further, incorrect nose poking remained high even following introduction of the
time out period for mice administered scopolamine. This suggests that scopolaminetreated animals were still seeking the reward, as in the operant familiarization and PreTraining phases of training, but were unable to learn that they should only nose poke in
response to the tone.
We were very interested in testing the bidirectionality of optical manipulation of
ACh signaling and first attempted to do this by using archaerhodopsin (Arch), the proton
pump inhibitory opsin (Chow et al., 2010). Unlike parameters for the contingentstimulation group, we designed the inhibitory laser to turn on with tone onset, because
waiting for correct nose poke would be too late (the mice would have already earned the
reward). However, the behavioral boxes used for those studies appeared to have some
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unexplained technical issues, so we were not able to obtain reliable data from the Arch
study. Almost all mice from both groups (control and Arch) in one of the boxes
performed poorly and never met acquisition criteria for the task. Future studies will
repeat the optical inhibition experiment after verification and characterization with dual
fiber photometry-optogenetic inhibition. I also attempted to use retrograde Cre-specific
Gi-coupled DREADDs to inhibit BLA-projecting cholinergic cells but was not successful
in getting expression of the DREADD in the NBM using this strategy. After discussion
with many colleagues suggesting that retrograde AAV’s may not be compatible with
cholinergic neurons, I used a canine adenovirus (CAV) multiple times, also without
success. My final attempt to inhibit cholinergic signaling in the BLA more selectively
involved using a short-hairpin RNA approach to knockdown expression of M1-type
mAChRs locally, but we failed to see expression of the associated fluorophore in the
BLA. Once again, this opens up the possibility of additional studies in the future.
Cell-type-specific expression of AChRs and activity-dependent effects place
cholinergic signaling at a prime position to shape BLA activity during learning. For
instance, late-firing interneurons in the BLA exhibit nAChR-dependent EPSPs when no
effect is seen on fast-spiking interneurons, while principal neurons can be either excited
or inhibited through mAChRs, depending on activity level of the neuron at the time of
cholinergic stimulation (Unal et al., 2015). BLA mAChRs can support persistent firing in
principal neurons and can be important for the expression of conditioned place preference
behavior, as well as trace fear conditioning (Baysinger et al., 2012; Egorov et al., 2006;
McIntyre et al., 1998). Similar to studies of trace fear conditioning, in which activity of
the network over a delay period must be maintained, we found that metabotropic
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(mAChRs) but not ionotropic (nAChRs) ACh receptors were required for learning the
contingency of this cue-reward task.
Scopolamine was given systemically before behavioral sessions, so we are unable
to determine whether the ability of mAChR antagonism to disrupt cue-reward learning
was a result of local effects in the BLA. In addition, this antagonist study could not
disentangle the effect of mAChRs on acquisition, consolidation, or recall in the cuereward learning task. Studies of inhibitory avoidance learning have implicated amygdala
ACh signaling in both acquisition and consolidation of avoidance learning, since basal
forebrain lesions impaired both aspects of the task, and this could be rescued by injection
of a muscarinic agonist (Power & McGaugh, 2002). In contrast, another rat study showed
that fear conditioning was impaired with pre-treatment, but not post-treatment, of
scopolamine (Anagnostaras et al., 1999). It is not clear if the same outcomes would be
seen for consolidation of cue-reward learning. Anecdotally, in our antagonist study, one
control mouse that had already acquired the reward learning task was inadvertently given
scopolamine on one of the Training days. Its correct nose pokes dropped and incorrect
nose pokes increased during that session but rebounded on the following day. Thus,
scopolamine could have impaired cue detection, since administration of the drug
immediately before a testing session acutely impaired performance after acquisition.
However, when scopolamine was given to the rest of the saline mice at the end of the
experiment to follow-up on this finding, only about half of the animals showed the same
change in behavior. Future studies replicating the systemic effects and using local
infusion of scopolamine into the BLA will be needed to determine whether mAChR
antagonism alters acquisition, recall, and/or cue detection.
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Systemic nAChR antagonism did not alter cue-reward learning. We have shown
that this dose of mecamylamine is sufficient to decrease anxiety-like behavior. Further,
treatment with this dose of mecamylamine is sufficient to decrease BLA activity as
measured by c-fos immunoreactivity (Mineur et al., 2007). However, it is still possible
that a higher dose of mecamylamine in vivo is necessary to block nAChRs that are
necessary for BLA plasticity leading to associational learning (Jiang et al., 2016). It is
important to note that even if we did not see impairment at a higher dose of
mecamylamine, this does not rule out nAChR involvement in the enhancement of
learning seen with optogenetic stimulation of ACh release in the BLA. Nicotinic
receptors mediate ACh-mediated EPSPs in interneurons (Unal et al., 2015) and gamma
band rhythmicity in the BLA (Aitta-aho et al., 2018). Thus, to truly make the claim that
nAChRs are not involved in the learning enhancement observed with NBM-BLA
stimulation, it would be necessary to administer mecamylamine (ideally locally) along
with stimulation of BLA ACh terminals.
In contrast to the lack of effect of the nAChR antagonist, we saw modest
improvements in behavioral performance in this task following subcutaneous nicotine
administration. Nicotine can potentiate responding for cues in an operant task, even when
given non-contingently (Caggiula et al., 2009). It should be noted that control mice
typically acquire the cue-reward task around day 8 of Training, however the control
group in the nicotine experiment reached acquisition criteria after only 6 days of training,
on average. This could be because these mice did not undergo surgery or because this
cohort was on the younger age range of mice tested (~5.5 months old). Thus, in a control
group with less efficient learning, it may be possible to observe a greater effect of
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nicotine on acquisition of the cue-reward behavior. In addition, only female mice were
tested in this experiment and since sex differences in nicotine’s effects on reward
enhancement have been described in rats (Donny et al., 2000; Flores et al., 2019), it is
important to test males in a future study.
The timing of cholinergic signaling can be a critical factor in the induction of
synaptic plasticity in other brain regions, so we hypothesized that the enhancement of
cue-reward learning observed might be dependent upon when NBM-BLA terminal fibers
were stimulated with respect to tone presentation and/or behavioral responses (Gu &
Yakel, 2011). However, we found that heightened ACh signaling in the BLA improved
behavioral performance even when stimulations were explicitly unpaired with the cue or
correct nose poking. This suggests that the effect of increased cholinergic signaling in the
BLA is long lasting, and that stimulation during a learning session is sufficient to
potentiate synaptic events linking the cue to a salient outcome—even if CS and/or reward
delivery are presented tens of seconds later. Given the findings from fiber photometry
recordings, which showed endogenous ACh release was time-locked to salient stimuli
during the task and evolved with learning, it is surprising that time-locking of exogenous
ACh release was not necessary for enhancement of cue-reward learning. Coupled with
pharmacological evidence demonstrating that muscarinic signaling is necessary for
reward learning in this task, these results suggest the involvement of metabotropic
signaling downstream of muscarinic receptors that outlasts the initial cholinergic
stimulation. This seeming contradiction will be explored further in Chapter 5.
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5. Chapter 5: General Discussion
The primary findings detailed in the previous chapters are summarized below.
Finding
ACh release in the BLA occurs in response to salient
events during cue-reward learning and evolved across
contingency acquisition

Figure(s)
Figure 3.1 - Figure 3.8

NBM-BLA neurons are, at least in part, responsible for the
ACh release during cue-reward learning

Figure 3.10 - Figure 3.18

BLA principal cell activity followed reward retrieval and
reward predictive cues

Figure 3.19 - Figure 3.25

Contingent and non-contingent optical stimulation of ACh
release in the BLA enhanced cue-reward learning in male
and female mice

Figure 4.2 - Figure 4.3,
Figure 4.8

Muscarinic, but not nicotinic, AChRs are required for cuereward learning

Figure 4.6

Nicotine administration modestly improves cue-reward
learning
Table 5.1. Summary of Primary Findings.

Figure 4.9

The abundant BF input to the BLA results in ACh release in response to stimuli
that predict reward in a learned cue-reward task. Increasing cholinergic signaling results
in accelerated learning of the cue-reward contingency. These findings are consistent with
the hypothesis that ACh is a neuromodulator that is released in response to salient stimuli
and suggests that ACh signaling may enhance neuronal plasticity in the BLA network,
leading to accelerated cue-reward learning. However, beyond this quick summary, there
is a paradox when integrating the primary results from Chapters 3 and 4. A graphical
summary (Figure 5.1) of the fiber photometry and optogenetic stimulation results serves
to highlight this conflict.
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Figure 5.1. Summary of cholinergic fiber photometry and optogenetic stimulation
results. A) Top: Based on fiber photometry recordings with ACh3.0 sensor and NBMBLA cholinergic terminal fibers, early in Training, the peak of ACh signaling followed
nosepoke but as mice acquired the task, the ACh signaling peaked following tone onset.
Bottom: Optogenetic stimulation of cholinergic NBM-BLA terminal fibers enhanced
learning when stimulation was both contingent and non-contingent with behavior.

The fiber photometry recordings of ACh signaling, via both the ACh3.0 sensor
and NBM-BLA cholinergic terminal fiber activity, indicate that ACh release is tightly
time-locked to different events across the learning paradigm. Early in Training, there is a
peak in ACh signaling following nose poke. As mice acquire the task, tone onset elicits
the ACh transient. However, optogenetic-mediated release of BLA ACh that spans cue
presentation, nosepoke, and reward availability enhanced the acquisition of the task,
causing mice to earn more rewards and make fewer incorrect nose pokes in both
contingent and non-contingent stimulation paradigms. Why does the timing of BLA ACh
signaling correlate with learning if this precise timing is apparently irrelevant for AChmediated enhancement of learning? The non-contingent stimulation results were our first
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clue that BLA ACh timing was curious. The non-contingent stimulation experiment
suggested that ACh’s effect on learning extends beyond the 2 sec of stimulation, which
was initially quite surprising but seemed plausible after considering that non-contingent
nicotine delivery can potentiate responding for visual cues (Caggiula et al., 2009). In
addition, pharmacological studies using the mAChR antagonist that impaired cue-reward
learning supported the case for ACh altering BLA function on a longer timescale, since
metabotropic mAChRs initiate signaling cascades that can persist well beyond the initial
triggering stimulus (Picciotto et al., 2012). When considering all of our results together
though, it was the contingent stimulation experiment that I found hardest to reconcile.
Through fiber photometry, we found that “expert” mice exhibit ACh signaling in the
BLA following tone onset, but optical stimulation contingent on correct nose poke is
more similar to the ACh signaling of a “novice” mouse. Any type of broad ACh
stimulation actually seems like it might disrupt learning if the precise timing of ACh
release in the BLA is crucial. For example, if ACh release is important for a prediction
error, experimenter delivered ACh stimulation should disrupt appropriate error
calculation and should impair behavior in the task. Thus, the experiments I propose
below are designed to address this conflict surrounding ACh timing.
The shift in timing of BF cholinergic signaling in the BLA may be a consequence
of learning, not the cause. It is clear that ACh release in the BLA can influence learning
seemingly regardless of the timing of release. Perhaps the large ACh transients we
observe shift networks to being more receptive to future learning? This might be
reasonable considering that an animal that earns an unexpected reward or experiences an
aversive outcome in the wild could benefit from putting its proverbial thinking cap on
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and being prepared to learn about upcoming predictive cues in that environment. ACh
signaling has been shown to potentiate firing of BLA neurons (Jiang et al., 2016; Unal et
al., 2015), enhance glutamate release and LTP between cortical-amygdala circuits (Jiang
et al., 2016), and increase BLA theta and gamma rhythmicity (Aitta-aho et al., 2018), all
of which could position the BLA in a state primed to form new associations between US
and CS. This possibility might explain why optically evoked ACh transients enhance
learning regardless of timing. In the context of our task, this would mean that ACh
release might work by influencing performance on subsequent trials. However, it is still
worth considering that even though we saw nearly identical enhancement of learning for
the nosepoke contingent and noncontingent stimulated mice, both of these optical
stimulation schedules might actually be suboptimal. An easy follow-up experiment to
address the timing question would be to compare a nosepoke contingent group to a tone
onset contingent group. It is possible that jumping straight to an “expert” mouse
phenotype of ACh signaling could hasten learning even more.
A relatively straightforward way to begin investigating the impact of ACh release
on subsequent trials is to look deeper into trial level dynamics in our existing datasets.
For instance, we could use a logistical regression and classify trials based on time since
last ACh transient, endogenous and/or optogenetically evoked, to test if ACh release
predicts likelihood that mice will make an incorrect nose poke or earn a reward. Future
experiments could test hypotheses generated from these analyses by repeating the
optogenetic experiment, but only delivering stimulation in half of the trials to see if more
stark differences emerge. Also, it is important to note that we don’t really know what the
mice are actually attending to in our cue-reward learning task. Mice could first learn that
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the tone predicts reward, that they should withhold incorrect nose pokes, or some
combination of both.
Another possibility is that ACh release in the BLA might influence plasticity of
cholinergic input itself. As mentioned earlier, BLA ACh can enhance the responding of
already excited principal neurons (Jiang et al., 2016; Unal et al., 2015). BLA principal
neurons that project to the nucleus accumbens (NAc) are preferentially excited by
reward-predictive cues compared to the BLA as a whole (Beyeler et al., 2016). Thus, if
NAc projecting BLA neurons (BLA-NAc) become active during our cue-reward learning
task and this activity is potentiated by BF ACh release in the BLA, the BLA-NAc input
could become integrated into the reward related computation in the NAc (Klawonn &
Malenka, 2018). Since the NAc projects to BF cholinergic neurons (Zaborszky et al.,
2012), this is a possible pathway for BF cholinergic neurons to impact their own
plasticity (Figure 5.2). This is purely hypothetical but could be evaluated by using fiber
photometry to measure both the BLA-NAc and NAc-BF projections during learning.

Figure 5.2. Simplified hypothetical pathway by which BF ACh neurons could
influence their own plasticity. Cholinergic NBM-BLA cells influence activity of
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glutamatergic BLA principal neurons. BLA cells that project to the NAc are
preferentially excited by reward predictive cues. GABAergic NAc output neurons that
project to NBM could allow NBM ACh neurons to influence their own plasticity during
reward learning. Note that this highly simplified diagram leaves off local interneurons
and other convergent outputs and inputs and is provided to generate hypotheses for
development of circuit-level experiments. NAc = nucleus accumbens, NBM = nucleus
basalis of Meynert, BLA = basolateral amygdala.

I think it is worth following these ideas to their logical extreme to ask, why should
the brain even bother with BF plasticity if it follows, instead of directs learning? Perhaps
the resulting plasticity in the BF could be useful when considering that BF cholinergic
neurons have extensive collaterals and that BF innervates wide swaths of the cortex in
addition to the BLA (Ballinger et al., 2016). Plasticity in BF cholinergic neurons that
project to a region like the mPFC could be important given findings that choline currents
in the mPFC follow cue detection (Parikh et al., 2007) and that optically evoking ACh
release enhanced cue detection (Gritton et al., 2016). However, hit rates (successfully
responding to a detected cue) were only increased when stimulating cholinergic BF cell
bodies, but not BF terminal fibers in the mPFC (Gritton et al., 2016). Similarly, optical
inhibition of these cholinergic BF cell bodies was sufficient to decrease hit rate while
inhibition of mPFC terminals was not. This might suggest that the role of ACh in signal
detection is mediated via a greater coordination of brain areas and not just release in the
mPFC. In looking at the effects of NBM-BLA cholinergic terminal fiber stimulation on
cue detection, we did see a significant increase in hit rate. Surprisingly though, contingent
stimulation happens after the animals have already detected the tone (since correct nose
poke is what triggers stimulation). This provides even more evidence that evoked BLA
ACh release is likely affecting behavior on subsequent trials. However, this difference is
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most pronounced early on, when both groups earn relatively few rewards, so a large
difference in hit rate could be due to just a few tones. Alternatively, it is possible that
ChR2 mice only exhibit a better hit rate because they are presented more tones, since they
are better at withholding incorrect nose pokes and are not in timeout. Accordingly,
conclusions we draw about hit rates should be tempered until we understand which
aspect(s) of the task is learned faster as a result of cholinergic NBM-BLA terminal fiber
stimulation.
A final note about the findings from the Sarter group that I found interesting: PFC
choline transients were only observed in response to detected cues that were not
immediately preceded by another hit (Howe et al., 2013). In other words, if the animal
just responded to a tone on the last trial, a consecutive hit did not elicit a choline
transient. The rats in the Howe et al. study were subjected to far shorter intertrial intervals
(9 ± 3 sec) than our mice were (10-50 sec, on average 30 sec), so it is difficult to make
direct comparisons. However, it should be possible to modify our task parameters to
allow for this. The conclusion drawn by the authors about these transients was that they
mediate a shift in state, from waiting for a cue to acting upon the detection of a cue
(Howe et al., 2013). If this interpretation is correct, it is perhaps a way to think about our
results suggesting that the effect of BLA ACh transients outlast their own existence.
Another study that deserves further exploration when considering our results is
from our collaborators, the Role and Talmage lab (Jiang et al., 2016). One key finding
from this study was that optogenetic stimulation of NBM-BLA cholinergic terminal
fibers did not hasten acquisition of fear learning or enhance cued freezing 24 hours later,
but it did delay extinction of cued freezing. In terms of enhanced learning and memory,
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these results are the opposite of those we found in our optogenetic studies. We observed
faster acquisition but no effect on extinction. To be sure, the fear conditioning and cuereward learning are quite different, appear to depend on different ACh receptors, and it is
impossible to know whether the learning in each task is of similar magnitude. It is
possible that because fear learning can occur so rapidly and be expressed so robustly,
Jiang et al. encountered a ceiling effect. Indeed, in our ACh3.0 recordings during fear
conditioning, we saw that even starting with the second tone presentation, there appears
to be a larger ACh transient, which provides evidence for single trial learning. Even with
these caveats, it is striking that the same neuromodulator (ACh), released in the same
brain area (BLA), originating from the same region (NBM), could affect learning of
opposite valence differentially. This differential impact, as well as many of the results
presented and discussed here, provide more evidence to suggest ACh is a modulator of
BLA output, but does not direct its activity.
Lastly, before detailing additional experiments I would like to carry out, I think it
is important to discuss a recent study that investigated the effect of cholinergic signaling
in the amygdala, and demonstrated that optically stimulating NBM-BLA terminal fibers
alone supported appetitive learning-related behaviors (Aitta-aho et al., 2018). Aitta-aho
and colleagues found that cholinergic NBM-BLA terminal fiber stimulation led to more
time spent on the laser paired side of a chamber during a test of real time place preference
and that mice would poke a touchscreen a modest number of times to receive that many
stimulations. I designed our real time place preference and cued self-stimulation tests
because of this study but was unable to replicate their results.
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After close reading of their methods, I noticed that their injection coordinates into
the NBM vary from ours. Despite their figure’s graphic depiction of their injection site
(which mirrors ours) their injection site coordinates (anteroposterior +0.05 mm, laterally
±1.15 mm, dorsally -5.0 mm from bregma) are actually in the ventral pallidum/substantia
innominata, when our injections are centered in the NBM/substantia innominata (-0.7
mm, ±1.75 mm, -4.5 mm). If these coordinates are not just simply an error in their
Methods section, it suggests that a different cholinergic subnucleus in the BF that also
projects to the BLA could have a very different effect on reward-related behavior, and
that these cholinergic neurons synapse onto or otherwise preferentially affect different
populations of BLA neurons. For instance, ventral hippocampal (vHPC) projecting BLA
(BLA-vHPC) neurons are responsive to cues of positive and negative valence equally
while, BLA-NAc neurons respond more to positive valence cues (Beyeler et al., 2016).
Indeed, Aitta-aho reported remarkable segregation of BF-BLA terminal fibers to the
basal, but not lateral, division of the BLA, which nicely maps onto the topographical
gradient of BLA-vHPC neurons (Beyeler et al., 2018). The terminal fibers observed from
our NBM injections were largely present throughout both the basal and lateral divisions
of the BLA, which would encompass both the BLA-vHPC and BLA-NAc neurons as
well as central amygdala projecting BLA neurons, which preferentially respond to
aversive cues (Beyeler et al., 2018). A more diffuse spread of cholinergic NBM-BLA
terminal fibers that interact with a broader subset of BLA neurons might explain why our
stimulation did not appear to have inherently appetitive or aversive value. Yet, this
topographical arrangement of projector populations does not explain why Aitta-aho et al.
found appetitive behaviors supported, since the BLA-vHPC neurons exhibit equal
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preference. However, there may be a mediolateral topographical bias for valence coding
in the BLA, where more the medial areas of the BLA, such as the basal region,
preferentially encode positive cues, which parallels the terminal fiber patterning Aittaaho et al. reported. It is conceivable that the intersection between topographical biases,
cholinergic terminal fibers projection pattern, and BLA-projector populations could in
part explain the differences between our studies. One way to study this would be to
compare our NBM-BLA terminal fiber distributions directly by injecting viral constructs
encoding different colored Cre-dependent fluorophores at our NBM coordinates and
Aitta-aho et al.’s ventral pallidum/substantia innominata coordinates. Even if we do not
see striking differences with this anatomical approach, we could inject a red-shifted
calcium sensor in the NBM and GCaMP in the ventral pallidum/substantia innominata to
determine if there are differences in cholinergic signaling dynamics.
I would like to shift the focus of the rest of this chapter to additional directions I
believe this work could and should go. The impetus for one series of experiments I plan
to carry out stems from the caveats that must be considered when attempting to integrate
our fiber photometry and NBM-BLA cholinergic terminal fiber optical stimulation data.
A central question is: how does optically evoked ACh release compare to endogenous
ACh release in the BLA? The simultaneous fiber photometry-optogenetics approach used
by Pisansky and colleagues provides an ideal way to answer this question (Pisansky et al.,
2019). This in vivo method involves using a red-shifted opsin to excite or inhibit a
population of neurons while recording from a green fluorescent biosensor. I plan to use
the channelrhodopsin variant ChrimsonR to excite NBM-BLA terminal fibers while
recording from ACh3.0 in the BLA, starting with the stimulation parameters used in our
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experiment and testing an array of light powers, frequencies, pulse widths, etc. to
construct dose response curves for optically evoked ACh release. I will compare those
results to the endogenous ACh release in the same mice as they perform the cue-reward
learning task to see how different our stimulation is. It is possible that our stimulation
results in much more ACh release and with far different kinetics than natural release.
Also, our ex vivo electrophysiological recordings suggest we may not have been eliciting
action potentials with pulses above ~10 Hz. Of note, recordings using this setup would
not be directly comparable to our ChR2 experiments, since it requires ChrimsonR, which
has different characteristics (Klapoetke et al., 2014). However, this study will be
important for understanding the differences between evoked and unmanipulated ACh
release in the BLA and would inform a replication optogenetic cue-reward learning
experiment with stimulation parameters that are more naturalistic.
The dual fiber photometry-optogenetic setup, which we have acquired the
components for, is also capable of optical inhibition (Pisansky et al., 2019). Given that I
have faced difficulties with optogenetic inhibition in the past but am still interested in
inhibiting NBM-BLA cholinergic terminal fibers during learning, I will characterize
halorhodopsin’s effect on BLA ACh signaling before embarking on the full cue-reward
learning paradigm with it again. In addition, with this setup and other fluorescent
neurotransmitter sensors (Marvin et al., 2013, 2018, 2019), we can determine whether
other neurotransmitters are co-released from NBM-BLA cholinergic terminals with our
stimulation parameters (Granger et al., 2016; Saunders et al., 2015).
With respect to the behavioral task itself, I am interested in modifying the task to
allow for richer data collection, as well as analyzing data at the single trial level instead
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of just at the session summary level. It would be helpful to incorporate omissions and to
vary the amount of reward delivered across trials in order to evaluate whether BLA ACh
signaling is indeed related to prediction error. Another modification of the task would be
to maintain the timeout period after an incorrect nosepoke response, but to remove the
timeout light in a replicate optogenetic stimulation experiment. This would tell us if the
enhancement in learning we observed was due to increased salience of this possibly
mildly aversive timeout light, rather than (or in addition to) enhancement of learning the
cue-reward contingency itself. If a stimulated group without a timeout light learns
similarly to controls, it would suggest that the effects of ACh could be related to
increasing the effects of an aversive stimulus. Trial level analysis of the ACh3.0
recordings would also provide insight into the question of whether ACh transients
diminish in magnitude across a session, for instance as mice become sated.
Finally, I would like to follow up one of my first observations from
baseline BLA ACh3.0 recordings and determine how it relates to trial level analyses
reward learning. Using the ACh3.0 sensor, there are clear, seemingly spontaneous,
periodic transients that are sometimes similar in size or larger than signals measured in
response to salient events in the behavioral task. Since these ACh transients are not
linked to the parameters we measure in the cue-reward task, they typically average out
across trials. Interestingly, even though it is not easily appreciated in the behavioral
session averaged data, there is a decrease in the frequency and amplitude of these
transients following reward retrieval. This quiescence is reflected in session averaged
data within and across mice as a significant decrease in ACh signaling. While it is
possible that this decrease in basal activity is due to quenching of the sensor following
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the large transient evoked by tone or nosepoke, the decrease appears to be dependent on
receiving a reward, because during early extinction session when animals exhibit similar
ACh transients following tone onset but do not receive reward for a nosepoke, this
quiescence is not apparent. There are several possible technical artifacts that I have
considered and am exploring but will not subject my audience to here. Yet, I do want to
share that the Kepecs group who recorded from ACh3.0 in BLA observed a similar
quiescence following reward receipt (Sturgill et al., 2020). This is interesting because it
raises the question of why these spontaneous transients diminish after reward. It may be
important for increasing signal to noise ratios in the BLA (transiently providing less
cholinergic input after robust release) and could be related to the input to the BF from
reward related areas like the NAc discussed earlier. Are learning related computations in
the BLA perturbed if this quiescence is absent? I plan to address these ideas in the future
because I believe it is important that we take a holistic view of BLA ACh signaling and
not just consider what increases ACh release mean, but also the involvement of
decreases.
The results I have shared here serve as one of the many building blocks
within the neuroscience community’s larger understanding of learning and memory. If we
hope to continue making progress in helping humans that suffer from learning and
memory related disorders, we must develop a clearer picture of which brain areas,
neurotransmitters, and rules contribute to experience of an event and recall of it later. At
least one key contribution to cue-reward learning is mediated by ACh signaling in the
BLA, and the studies described here lay out numerous directions that can be taken in the
future to determine the detailed mechanisms through which this occurs.
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Appendix 1. Fiber photometry supplemental table. A-D) Number of mice that
acquired the reward learning behavior, number that were excluded and any training
deviations for experiments in Chapter 3. A) Mice in the initial BLA ACh3.0 group were
trained outside of the sound attenuating chambers. These mice had 5 days of Pre-Training
because they were trained concurrently with another cohort of mice (not shown) that
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required an extra day to reach two consecutive days of 20 rewards earned and were
advanced to a VI 20 schedule of reinforcement during Training after 9 days to promote
responding. Training was extended to allow all mice to acquire. Due to time constraints
during acquisition, mouse 3 in this cohort was moved to Extinction after 20 days of
Training because it had acquired earlier, was earning the most rewards, and we wanted to
record more extinction days. B) Mice in the BLA ACh3.0 and NBM-BLA terminal fiber
replicate experiments were advanced to one day of Extinction after only 7 days of
Training due to the COVID-19 shutdown. C) BLA ACh3.0 and NBM-BLA terminal fiber
jRCaMP1b mice were analyzed as dual channel mice just through Pre-Training and were
instead used as replicates of the BLA ACh3.0 experiment. One of the mice had apparatus
errors during Training and had to be excluded. D) Mice in the initial BLA CaMKIIα
GCaMP6 were trained outside of the sound attenuating chambers. Mouse 1 progressed
from Pre-Training to Training a day earlier than the rest of the group and was able to
have an extra day of Training before the 2 days of Extinction. Mice in this group were
advanced to a VI 20 schedule of reinforcement during Training after 6-7 days to promote
responding. Training was extended to allow more mice to acquire.
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Appendix 2. Cholinergic manipulation supplemental table. Number of mice that
acquired the reward learning behavior and number that were excluded for each
experiment in Chapter 4.
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Appendix 3. Injection sites and optical fiber placements for Figure 4.2. A) Circles
indicate NBM injection sites for individual mice, EYFP (green) and ChR2 (blue).
Anterior/posterior position relative to Bregma indicated. B) Squares indicate observable
optical fiber tips for individual mice, EYFP- (green) and ChR2-expressing mice (blue).
Triangles indicate estimated optical fiber tips based on adjacent slices. Anterior/Posterior
position relative to Bregma indicated.
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Appendix 4. Injection sites and optical fiber placements for Figure 4.3 A) Circles
indicate NBM injection sites for individual mice, EYFP- (green) and ChR2-expressing
mice (blue). Anterior/posterior position relative to Bregma indicated. B) Squares indicate
observable optical fiber tips for individual mice, EYFP- (green) and ChR2-expressing
mice (blue). Triangles indicate estimated site of optical fiber tips based on adjacent slices.
Anterior/posterior position relative to Bregma indicated.
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Appendix 5. Injection sites and optical fiber placements for Figure 4.8. A) Circles
indicate NBM injection sites for individual mice, EYFP-expressing (green), contingentChR2-expressing (blue), and non-contingent-ChR2-expressing mice (cyan).
Anterior/posterior position relative to Bregma indicated. B) Squares indicate observable
optical fiber tips for individual mice, EYFP-expressing (green), contingent-ChR2expressing (blue), and non-contingent-ChR2-expressing mice (cyan). Triangles indicate
estimated site of optical fiber tips based on adjacent slices. Anterior/posterior position
relative to Bregma indicated.
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